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I. SUMMARY 
Mutations in tetratricopeptide repeat domain 7A (TTC7A) and its mouse orthologue Ttc7 
— a ubiquitously expressed protein — result in a life-threatening multisystemic disease, 
severely affecting epithelial body barriers and the immune system. Patients mainly suffer 
from intestinal atresias and immunodeficiency. Furthermore, surgical treatment of the 
atresias is associated with poor outcomes, and the potentially fatal condition progresses 
despite successful allogeneic hematopoietic stem cell transplantation. There is an 
ongoing debate of whether TTC7A mutations uniquely dysregulate epithelial cells, or 
whether a defect in lymphocytes contributes to the pathogenesis of the disease. 
Therefore, a deeper understanding of mechanisms underlying the multisystemic nature 
of TTC7A deficiency is needed.  
 
The flaky skin mutant mouse  (Ttc7fsn/fsn) has been regarded as a model for human 
psoriasis because of its hyperplastic skin disease. Ttc7fsn/fsn mice present with a severe 
hyperplastic dermatitis as the main feature of a complex phenotype including a 
hyperproliferative immune disorder (splenomegaly and peripheral lymphadenopathy), 
gastric forestomach papillomas, and anemia. The mechanisms leading to the flaky skin 
phenotype remain largely unknown. In particular, it is unclear whether the hyperplastic 
skin disease is uniquely due to an intrinsic epithelial dysfunction or if altered immune 
activation leads to reactive epidermal hyperplasia. To investigate this, we generated 
double homozygous mutant Rag2-/-Ttc7fsn/fsn mice — lacking adaptive lymphocytes — and 
triple homozygous mutant mice Rag2-/-IL2rg-/-Ttc7fsn/fsn mice — completely lacking the 
innate and adaptive lymphocytic compartment. Both immunodeficient mouse strains 
were not protected from epithelial hyperproliferation and even developed peripheral 
lymphadenopathy but less severe than observed in the Ttc7fsn/fsn mouse model. 
Furthermore, the transfer of Ttc7-mutated hematopoietic stem cells did not induce 
epithelial hyperproliferation or peripheral lymphadenopathy in wild-type animals. Thus, 
lymphocytes are able to aggravate the severity of epithelial hyperproliferation and 
inflammation in Ttc7fsn/fsn stroma but cannot elicit the flaky skin phenotype. Serum 
cytokine profiles revealed high levels of IL-22 in single, double and triple homozygous 
mutant mice. We herewith identified non-lymphoid Ttc7fsn/fsn cells as the major source of 
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IL-22. ln a xenograft model, Ttc7-mutated mouse fibroblasts markedly increased 
epithelial proliferation of human keratinocytes. The analyses of transcriptomic data from 
Ttc7-mutated fibroblasts displayed an mRNA expression pattern that suggested 
alterations in phosphoinositide-dependent signaling pathways. These pathways play an 
important role in cytoskeleton regulation and in cell-cell-interactions. In addition, we 
found an increased expression of IGF-1. Consequently, Ttc7-mutated fibroblasts were 
identified to critically induce the hyperproliferative behavior of keratinocytes in the 
presence of the proliferation-inducing factors IL-22 and IGF-1. 
Our work shows that fibroblasts harmfully alter the dynamic and behavior of epidermal 
cell maturation, while Ttc7-mutated lymphocytes contribute to epidermal homeostasis. 
The dysfunctional crosstalk between stromal cells adds an unsuspected new dimension 
to the pathogenesis of the multisystemic disease associated with TTC7A deficiency. This 
suggested mechanism reveals why previous HSCT treatments together with intestinal 
surgery may only partially relieve the multisystemic disease seen TTC7A-deficient 
patients. Thus, a new targeted therapeutic approach is needed to achieve treatment 
strategies that intervene in the disturbed interaction between stromal cells. 
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II. ZUSAMMENFASSUNG 
Tetratricopeptid-Repeat-Domäne 7A (TTC7A) ist ein Protein, welches in allen Körperzellen 
exprimiert wird, über dessen Funktion jedoch wenig bekannt ist. Mutationen im TTC7A-
Gen und dessen Maus-Ortholog Ttc7 verursachen eine lebensbedrohliche 
multisystemische Erkrankung bei der die Epithelbarrieren des Körpers und das 
Immunsystem stark beeinträchtigt sind. Die Patienten leiden hauptsächlich an 
intestinalen Atresien und einer Immunschwäche. Trotz Darmoperationen und 
erfolgreicher hämatopoietischer Stammzelltransplantation kann die intestinale 
Manifestation weiter fortschreiten. Unklar ist, ob die Mutationen in TTC7A ausschliesslich 
eine Funktionsstörung von Epithelzellen hervorrufen, oder zugleich eine zell-intrinsische 
Dysfunktion in Lymphozyten verursachen.   
 
Die „flaky skin“ Maus (mit homozygoter Ttc7fsn/fsn Mutation) wurde ursprünglich, aufgrund 
ihrer Hauterkrankung, als Modell für Psoriasis verwendet. Das Hauptmerkmal der 
Ttc7fsn/fsn-Maus ist eine schwerwiegende hyperplastische Dermatitis, die begleitet ist von 
einer hyperproliferativen Immunerkrankung (Splenomegalie und periphere 
Lymphadenopathie), der spontanen Bildung von Magenpapillomen und einer schweren 
Anämie. Anhand des „flaky skin“ Mausmodells sind wir der Frage nachgegangen, ob die 
homozygote Ttc7fsn/fsn Mutation ausschliesslich Epithelzellen beeinträchtigt, oder ob auch 
andere Zellarten betroffen sind. Dazu wurden immundefiziente Mausmutanten, denen 
adaptive Lymphozyten fehlen — zweifach homozygot mutierte Rag2-/-Ttc7fsn/fsn Mäuse — 
und Mausmutanten, denen sowohl Lymphozyten des adaptiven, als auch diejenigen des 
angeborenen Immunsystem fehlen — dreifach homozygot mutierte Rag2-/-IL2rg-/-Ttc7fsn/fsn 
Mäuse — gezüchtet und untersucht. Beide Mausmutanten haben eine entzündliche 
Hyperplasie der Haut und periphere Lymphadenopathie entwickelt. Der Schweregrad 
dieser Veränderungen war jedoch geringer in den zweifach- und dreifach mutierten 
Mäusen im Vergleich zur „flaky skin“ Maus mit nur einer Mutation. Zudem zeigten 
Wildtyp-Mäuse nach Transfer von Ttc7-mutierten hämatopoetischen Stammzellen 
unauffällige Hautverhältnisse und normale Lymphknoten. Es ist also davon auszugehen, 
dass Lymphozyten die Hyperproliferation des Epithels und die Entzündung des Stromas 
verschlimmern können, jedoch nicht den Phänotyp auslösen. Im Blutserum von allen 
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mutierten Mäusen haben wir einen erhöhten Wert des proliferations-induzierenden 
Zytokins IL-22 gemessen. Da auch bei zweifach- und dreifach mutierten Mäusen stark 
erhöhte IL-22 Werte vorlagen, waren nicht-lymphozytäre Ttc7fsn/fsn-Zellen die Hauptquelle 
der IL-22-Produktion. In einem Xenotransplantat-Modell haben wir festgestellt, dass 
isolierte Ttc7-mutierte Mausfibroblasten im Stande waren eine Hyperproliferation 
menschlicher Keratinozyten zu induzieren. Die Transkriptom-Analyse von Ttc7-mutierten 
Fibroblasten zeigte ein mRNA Expressionsmuster, welches auf Veränderungen in 
Phosphoinositid-abhängigen Signalwegen schliessen. Diese Signalwege spielen eine 
wichtige Rolle in der Zytoskelett-Regulierung und in Zell-Zell-Interaktionen. Zusätzlich 
fanden wir eine erhöhte Expression von Wachstumshormon IGF-1 in den Ttc7-mutierten 
Fibroblasten. Zusammenfassend lässt sich sagen, dass Ttc7fsn/fsn-mutierte Fibroblasten 
eine vermehrte Keratinozytenproliferation auslösen, und dass dies in Anwesenheit der 
proliferations- und wachstums-induzierenden Faktoren IL-22 und IGF-1 geschieht.  
Unsere Arbeit zeigt, dass Ttc7 in Fibroblasten die Dynamik und das Verhalten epidermaler 
Zellen beeinflussen kann, und dass Ttc7 in Lymphozyten bei der Kontrolle der 
Hauthomöostase mitwirkt. Wir postulieren deshalb, dass Mutationen in Ttc7 eine Störung 
in der Wechselwirkung zwischen Stromazellen verursachen und damit zur Pathogenese 
der multisystemischen Erkrankung beitragen während Lymphozyten eine 
untergeordnete Rolle spielen. Dies würde erklären, weshalb eine TTC7A-Defizienz nicht 
mittels Darmoperationen und hämatopoietischer Stammzelltransplantation geheilt 
werden kann. Ein neuer Therapieansatz wird benötigt, der gezielt in die gestörte 
Wechselwirkung zwischen Stromazellen einzugreifen vermag. 
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III. INTRODUCTION 
 
We are continually exposed to pathogens and irritants that are inhaled, swallowed, 
sitting on our skin or mucous membranes. The essential function of our immune system 
is best illustrated when something goes wrong resulting in inflammation, infections, 
allergies, immunodeficiencies, or autoimmune diseases. Mutations in the 
tetratricopeptide repeat domain 7A (TTC7A) result in a life-threating multi-systemic 
disease affecting epithelial barriers and the immune system. This thesis focuses on the 
mouse orthologue Ttc7 in the flaky skin mutant model presenting with anemia, a 
hyperproliferative immune disorder and a hyperplastic skin disease. Our intention was 
to gain a deeper understanding of the mediator(s) causing the multi-systemic disease in 
this mouse model with the aim to better understand the mechanisms that underlie the 
pathology in mice and men. 
 
1. The Hematopoietic System – Hematopoiesis 
Hematopoiesis comprises the formation and development of all blood cell lineages, 
that are, the red blood cells, the lymphocytes and the myeloid cells (incl. thrombocytes) 
(Figure 1). Hematopoiesis starts in the yolk sac during embryogenesis and, as 
development progresses, occurs in the spleen, liver, and lymph nodes. Eventually, the 
bone marrow assumes this task and forms most of the blood cells. Extramedullary 
hematopoiesis stops in humans after birth, whereas it remains a normal finding in the 
spleen of some species such as the mouse [1]. Hematopoietic stem cells (HSC) are self-
renewing and pluripotent, meaning that a single HSC can generate all different types of 
blood cells, respectively, white and red blood cells [2]. The HSC can be divided into 
short-term reconstituting HSC, which have a limited self-renewal potential and arise 
from long-term reconstituting HSC [2, 3]. The short-term reconstituting HSCs give rise to 
multipotent progenitors (MPPs), which, in turn, generate lineage-committed 
oligopotent progenitors, including (i) common lymphoid progenitors (CLPs) and (ii) 
common myeloid progenitors (CMPs) [2]. The CLPs differentiate into precursors of T and 
B lymphocytes, natural killer cells and subtypes of dendritic cells. The CMPs evolve into 
 INTRODUCTION 
! 11 
precursors of mature erythrocytes, platelets, granulocytes, and 
monocytes/macrophages [2, 3]. Most dendritic cells arise from CMP progenitors. 
 
 
Figure 1. Diagram of the hematopoiesis scheme. Hematopoietic stem cells are generated from a small population 
of hematopoietic stem cells (HSCs). HSCs can be divided into long-term (LT-HSC) and short-term reconstituting HSCs 
(ST-HSC). ST-HSCs maintain multipotency and give rise to multipotent progenitors (MPPs), which, in turn, generate 
lineage-committed oligopotent progenitors, including common lymphoid progenitors (CLP) and common myeloid 
progenitors (CMP). The precursors of megakaryocyte-erythrocyte progenitors (MEP) and granulocyte-monocyte 
progenitors (GMP) give rise to erythrocytes or granulocytes. Figure adapted from [2]. 
 
2. The Immune System  
The immune system can be divided into the innate (natural) and adaptive (acquired) 
immune system. Failure in one of these systems will greatly increase the susceptibility 
to infection.  
Anatomic and physical barriers provide the crucial first line of defense against 
pathogens and can be regarded as part of the innate immune system. An intact skin, 
mucociliary clearance mechanisms, low stomach pH, saliva, and other enzymatic-
enriched secretions belong to this group.  
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2.1. The innate immune system 
The innate immune system consists of hematopoietic-derived cells, which can be 
further classified into polynuclear granulocytes (neutrophils, eosinophils, basophils, and 
mast cells), mononuclear granulocytes (monocytes and tissue-resident macrophages), 
Langerhans cells, dendritic cells, natural killer (NK) cells and innate lymphoid cells (ILCs), 
and natural killer (NK) T cells. Most innate immune cells function as sentinel cells and 
populate the sites of body barriers. Innate immune cells possess a repertoire of pattern 
recognition receptors (PRRs), including Toll-like receptors (TLRs), NOD-like receptors 
(NDRs), complement receptors (CR), and killer-cell immunoglobulin-like receptors (KIRs) 
[4, 5]. 
 
2.2. The adaptive immune system 
The adaptive immune system is composed of highly-specialized systemic T and B 
lymphocytes. The adaptive immune response holds an extremely diverse and randomly 
generated collection of cell receptors (T cell receptor (TCR) and B cell receptor (BCR)) 
produced by a somatic recombination mechanism, which, in turn, leads to the antigen-
dependent and antigen-specific functionality of this system [6]. Antigen presentation 
plays a central role in generating adaptive immunity and is performed by antigen-
presenting cells (APCs) of the innate immune system, mainly dendritic cells and 
macrophages as well as by B cells [7]. 
 
Taken as a whole, the different immune cells orchestrate barrier surveillance by an 
interaction of the innate and adaptive immune system. 
 
2.3. Innate immune cells 
Monocytes are completely dependent on macrophage colony-stimulating factor (M-
CSF) for their development and survival especially in mice. Monocytes are 
heterogeneous and consist of different subsets distinguishable by their surface markers 
and functions [8]. In mice, the “classical monocytes” are defined by CD11b, a 
glycoprotein also known as integrin alpha M, and by high lymphocyte antigen 6 C 
expression (Ly6CHi), a part of the granulocyte differentiation antigen 1 (Gr-1). These 
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monocytes are rapidly recruited to the site of infection or tissue injury and can act as 
precursors of peripheral mononuclear phagocytes by differentiating into macrophages 
and dendritic cells [9].  
 
Macrophages represent the mature form of monocytes and are resident in almost all 
tissues, where they take various forms (with various names) in a highly heterogeneous 
manner with a multifunctional character [10-12]. One major function of macrophages is 
to ingest and kill microbes by fusing the trapped microbe in the phagosome with a 
lysosome, harboring enzymes and free radicals, which help to destroy the microbe [13]. 
On the other hand, macrophages display also regulatory and protective roles [13]. 
Inflammation-induced macrophages (by LPS or Interferon-γ (IFN-γ)) are called 
“classically activated” macrophages (M1 macrophages) [14]. They defend the host from 
a variety of pathogens and have roles in antitumor immunity. Macrophages stimulated 
by interleukin-4 (IL-4) or IL-13, referred to as M2 macrophages, have 
immunosuppressive and anti-inflammatory roles and are important in wound healing 
[14]. They sense signals, which are associated with invading pathogens and dying or 
dead cells, through pattern-recognition receptors including Toll-like receptors or C-type 
lectin receptors, and they play an important role in the clearance of apoptotic cells 
(termed efferocytosis), and in the remodeling of the extra cellular matrix, which has 
been described in detail [13, 15]. Most murine macrophages are defined by the 
expression of CD11b in combination with F4/80, a member of the epidermal-growth-
factor (EGF)-transmembrane 7 family. Different expression intensities define varying 
macrophage subtypes within a tissue. 
 
Eosinophils are granulocytes that express cytoplasmic granules containing cytotoxic 
enzymes and are important for parasite defense. Under baseline conditions, they are 
mostly found in mucosal linings of the respiratory and gastrointestinal tracts. Their 
number can massively increase at the site of inflammation, where they then release 
their cytotoxic granules in “bit-by-bit” degranulation steps into the extracellular space. 
Upon immunoglobulin, complement and particularly IL-5 activation eosinophils secrete 
various pro-inflammatory cytokines and chemokines [16, 17]. In general, IL-5 has a 
central role in maturation and differentiation of eosinophils [18]. Along with other 
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surface markers, eosinophils in mice can be defined by the expression of CD11b+ Siglec 
F+ (CD170). 
 
Basophils represent the smallest subset of granulocytes. They differentiate from the 
granulocyte-monocyte progenitors and fully mature in the bone marrow. Under normal 
conditions, they are found the in the periphery. During parasitic infections or allergies 
they migrate into the affected tissue [19, 20]. Basophils are a major source of IL-4 and 
can even function as antigen-presenting cells inducing differentiation of naïve T cells 
into T helper 2 (Th2) cells [21].  
 
Mast cells arise from common myeloid progenitors. Mast cells mature under the 
influence of the c-kit receptor (CD117) and the stem cell factor (SCF), which is mainly 
produced by fibroblasts, while IL-3 plays another supportive role in growth and 
differentiation [22]. Mast cells reside in connective tissue at sites that are exposed to the 
external environment, such as the skin, the airways and the intestine. They patrol in 
areas below the epithelium and are placed to function as sentinel cells in host defense 
against microbes and parasites. The most common way to activate mast cells is by 
crosslinking IgE-Fcε Receptor 1 (Immunoglobulin E; FcεR1) with an antigen (such as an 
allergen) [23]. Mast cells are also involved in physiological functions, including 
vasodilation and angiogenesis [24]. Mast cells store granules with a combination of 
inflammatory mediators including histamine, heparin, and a variety of cytokines, 
chemokines, growth factors and antimicrobial peptides [25]. In mice mast cells can be 
defined by the surface expression of c-kit and FcεR1. 
 
Neutrophils play a major role in the first line of defense against invading pathogens. 
The granulocyte colony-stimulating factor (G-CSF) is the predominant factor regulating 
proliferation, survival, differentiation, and trafficking/mobilization [26]. Also, IL-3 and IL-
6 play an additional role for proliferation and granulocytic differentiation [27]. 
Neutrophils are the most abundant and important factors in the innate immune 
response [28]. Neutrophil effector functions include phagocytosis, the formation of 
effector granules, respiratory burst, NETosis (neutrophil extracellular trap — NET), and 
cytokine production [29]. Neutrophils are defined by the expression of CD11b together 
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with the lymphocyte antigen 6 complex – locus G (Ly6G), a part of the granulocyte 
differentiation antigen 1 (Gr-1) [30]. 
 
Dendritic cells (DCs) play an important role in the innate and adaptive immune system. 
DCs can be divided into three groups: (1) the conventional DCs (cDCs), (2) plasmacytoid 
DCs and the (3) inflammatory DCs [31]. Dendritic cells are rare cells but widely 
distributed in the majority of tissues. Dendritic cells are equipped with various 
pathogen-recognition receptors, allowing them to sense the environment, and express 
major histocompatibility complex (MHC) class I and class II molecules to present 
antigens. In general, DCs are specialized in the capture, processing, and presentation of 
antigens to naïve CD4+ T cells. Depending on the type of DC and its activation state, the 
DC-T cell interaction leads to the initiation of an immune response or to T-cell tolerance 
[31, 32]. In mice, classical DCs are defined as CD11cHi MHC class II+ cells [33]. 
 
Natural Killer cells – Innate Lymphoid cells arise from the common-myeloid 
progenitor and represent a diverse population of cells that have lymphoid 
characteristics but lack the V(D)J-rearranged antigen receptors [34]. They play a role in 
the innate immune system. ILCs can maintain homeostasis in epithelial surfaces (e.g. 
skin, gastrointestinal tract, and respiratory tract) by responding to locally produced 
cytokines [34]. 
ILCs have been classified into three groups:  
(1) ILC1 cells, which include conventional NK cells, express the transcription factor 
T-bet, which cooperates with eomesodermin — the transcription factor of NK 
cells [35]. ILC1 cells produce the T helper type 1 cytokine IFN-γ [36].  
(2) ILC2 cells, which include nuocytes and natural helper cells, express the 
transcription factor GATA-3 and produce typical T helper type 2 cytokines IL-5 
and IL-13 [36].  
(3) ILC3 cells, which include lymphoid tissue-inducer cells (LTi), are crucial for 
lymph node development, express the transcription factor RORγt and produce 
effector molecules IL-17, IL-22, and they may also secrete IFN-γ and IL-13 [36]. 
Altered epithelial barrier function seems to be a key point in activation of ILCs to 
promote inflammatory responses [37]. The ILCs take part in the initiation and 
maintenance of defense against infections as well as immune-mediated diseases. Also, 
 INTRODUCTION 
! 16 
NK cells have been described to act against viral infections and are involved in tumor 
immune surveillance. The development and functional activities of ILCs and NK cells are 
controlled by several factors among which the usage of the common cytokine-receptor 
gamma chain (γc or CD132; part of the IL-2 Receptor — IL2RG) plays a major role. In 
particular, IL-2, IL-7, IL-9, IL-15 and IL-21 are the members of this family predominately 
involved in the biology of NK and ILCs, respectively [38].  
 
The Natural Killer T cells carry a TCR with an limited diversity of the TCRα chain and a 
restricted-assortment of TCRβ chains which are generated by somatic V(D)J gene 
rearrangement in the thymus [39]. These Type 1 Natural killer T cells are also called 
invariant natural killer T cells (iNKT) and are classified as CD1d-restricted T cells. The 
ability of these cells is to recognize alpha-galactosylceramide (α-GalCer) in association 
with CD1d-mediated presentation [40]. CD1d – a non-polymorphic major 
histocompatibility complex (MHC) class I-like molecule – is expressed by several cells of 
hematopoietic origin. NK T cells act at the interface between innate and adaptive 
immune response [40].  
 
2.4. Adaptive immune cells 
Both, T and B lymphocytes are the key players of the adaptive immune system. In 
response to pathogens, naïve T and B lymphocytes undergo activation and 
proliferation, giving rise to progeny with effector and memory fates that are able to 
mediate immediate long-term protection. 
 
T Lymphocytes 
The progenitors of the immature form of T lymphocytes develop in the bone marrow 
and mature in the thymus, where they become naïve T cells [41]. The thymus represents 
an epithelial-mesenchymal tissue, anatomically structured into cortical and medullary 
regions that contain stromal cells and epithelial cells, and the thymus supports the 
differentiation and selection of T cells [42]. The cortical thymic epithelial cells (cTECs) 
and medullary thymic epithelial cells (mTECs) interact with developing thymocytes and 
provide essential signals during thymopoiesis [43]. Lymphoid progenitors enter the 
thymus through blood vessels at the cortico-medullary junction, and then migrate 
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through the cortex to the subcapsular zone as CD4-CD8- double negative (DN) 
thymocytes. Following pre-T-cell receptor (TCR)-mediated selection, DN thymocytes 
mature into CD4+CD8+ double positive (DP) thymocytes that accumulate in the outer 
cortex. The positive selection of DP thymocytes in the cortex results in further 
maturation to CD4+ and CD8+ single positive (SP) thymocytes that migrate back across 
the cortex toward the thymic medulla where positively selected SP cells interact with 
mTECs to complete thymocyte development and ensure central tolerance. During T cell 
development, T cells undergo TCR gene rearrangements – V(D)J recombination process 
– to form their lineage-specific TCR, upon which their function will depend. [41]. These 
cells are divided into two groups: (1) αβ-recombined TCR T cells or (2) γδ-recombined 
TCR T cells [44]. αβ T cells additionally express CD4 or CD8 glycoproteins [45]. The CD3 
complex associates non-covalently with the T cell receptor of αβ T cells and γδ T cells 
[46].  
Depending on molecular signals present in their milieu in peripheral lymphoid organs, 
different subpopulations of effector helper αβ T cells can develop. The T helper cells 
express CD4, and the TCR binds antigens presented with MHC class II molecules. Each 
sublineage secretes a unique pattern of cytokines and generates a specific function to 
regulate immune responses (summarized in Figure 2) [47]. 
 
 
Figure 2. αβ T helper subtypes. Activation and differentiation of naïve T helper progenitors (Thp) into different 
subtypes of effector T helper cells. Corresponding transcription factors and signal transducer and activator of 
transcription (STAT) are marked below each T helper cell. Priming cytokines to induce differentiation are written 
along black arrows. The unique cytokine pattern and function of each T helper effector cell are noted next to each T 
cell. Figure adapted from www.open.nil.nih.gov. 
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Activated CD8+ T cells are also called cytotoxic T cells (CTLs). The TCR of CD8+ T cells 
bind antigens presented with MHC class I molecules, which are expressed on every cell 
[48]. The transcription factors T-bet and eomesodermin are involved in the fine-tuning 
of CD8+ effector (CLTs) and memory T cell differentiation. IL-2 promotes proliferation 
and differentiation of CD8+ T cells into CTLs and memory cells. IL-15 is important for the 
survival of memory CD8+ T cells. After clonal expansion, activated CD8+ T cells patrol the 
internal environment in search of infected cells. CD8+ T effector cells secrete tumor 
necrosis factor alpha (TNF-α) and IFN-γ, which have anti-tumor and anti-microbial effect 
[49]. Cytotoxic effector T cells can kill by permeabilizing the membrane of malignant 
cells with the help of perforin — which is stored in granules — and induce apoptosis via 
granzyme-induced caspase activation or the Fas/FasLigand pathway.  
 
γδ T cells are a subset of effector lymphocytes with a unique TCR comprising variant 
combination of a γ-chain  and δ-chain. They play a pivotal role in the first line of defense 
against microbes in epidermal and mucosal barriers and are therefore important for the 
surveillance of body barriers. Effector IFN-γ-producing γδ T cells express the 
transcriptional regulator T-bet, whereas IL-17-producing γδ T cells development 
involves RORγt [44].  
 
T cell-mediated immune responses to an antigen usually result in the generation of 
memory T cells specific for that antigen, which may persist for years, even a lifetime. The 
transcription factor Blimp-1 and the cytokines IL-7 and IL-15 are important for the 
generation and maintenance of memory T cells. 
 
B Lymphocytes 
The maturation of B cells from progenitors committed to this lineage occurs mostly in 
the bone marrow and before birth in the fetal liver. Fetal liver-derived stem cells give 
rise mainly to B-1 cells with less diverse antigen receptors. In the bone marrow B 
precursor cells form a premature functional B cell antigen receptor (BCR) — generated 
by V(D)J recombination — and are tested for autoreactivity to maintain central 
tolerance mediated by receptor editing and negative selection [50]. Immature 
transitional B-2 cells then migrate into peripheral lymphoid organs (lymph nodes and 
spleen) and develop into (i) marginal-zone B cells or (ii) follicular B cells. In contrast to 
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follicular B cells, marginal-zone B cells produce antibodies with very limited diversity. 
With the help of follicular dendritic cells and follicular helper T cells — together with 
activated B cells — germinal centers (GCs) are formed and maintained in secondary 
lymphoid organs [51]. Within GCs, memory B cells are generated, and B cells secreting 
high-affinity immunoglobulins (Ig) (affinity maturation) develop and differentiate into 
specific antibody-producing plasma cells, diversified by somatic hypermutation of the 
immunoglobulin variable gene segments [52-54]. Helper T cell-derived signals, 
including CD40L and different cytokines, induce isotype switching in B cells. Upon 
activation, B cells have the capacity to produce different antibody isotypes, which 
provide a remarkable plasticity to perform distinct effector functions. The outcome of B 
cell differentiation is regulated by the induction and activation of different transcription 
factors and transcriptional activators. The transcription factors Blimp-1 and IRF4 commit 
activated B cells to plasma cells, and Pax5 is required for the maintenance of mature B 
cells.  
B cells can be defined by the expression of CD19, which assembles with the BCR and 
regulates B cell development, activation, and differentiation [55]. 
 
The function of immune cells of the innate and adaptive immune system is rather 
complementary so that defects in either system results in the host’s vulnerability. 
 
3. Primary Immunodeficiency 
Primary immunodeficiency diseases (PIDs) are a group of rare diseases caused by 
genetic defects. The clinical features are highly variable, but they all result from a defect 
in one of the functions of the body’s normal immune system. Most primary or 
congenital immunodeficiencies result in an increased susceptibility to infections and 
may lead to immune dysregulation. Most PIDs are diagnosed in infancy and early 
childhood, but sometimes they are clinically detected later in life. 
Today, over 300 different single-gene inborn errors have been described, and they are 
characterized by genetic mutations. PIDs are classified according to the component of 
the immune system that is primarily involved into 1. immunodeficiencies affecting 
cellular and humoral immunity, 2. combined immunodeficiencies with syndromic 
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features, 3. predominantly antibody deficiencies, 4. diseases of immune dysregulation, 
5. congenital defects of phagocyte number, function or both, 6. defects in intrinsic and 
innate immunity, 7. autoinflammatory disorders, and 8. complement deficiencies [56, 
57]. The immunodeficiencies affecting “cellular and humoral immunity” arise from 
defects affecting T lymphocytes. Severe combined immunodeficiencies (SCIDs) arise 
from a complete lack in T cell development and, in some cases also block other 
lymphoid lineages. The study of human T-cell PIDs with Mendelian inheritance has 
enabled the molecular characterization of important key functions and pathways in T-
cell biology. Mutations in the recombinase activating genes (RAG1/2) — RAG1/2 genes 
are important to form functional T cell receptors during thymopoiesis — and (ii) 
mutations in the common cytokine receptor gamma chain (IL2RG) lead to defects in T-
cell differentiation and the premature death of progenitor cells resulting in the typical 
SCID phenotype, characterized by a virtual lack of circulating autologous T lymphocytes 
and absence of functional T-cell responses. Not only lymphoid cells can be affected; for 
instance, in the case of reticular dysgenesis, mutations in the adenylate kinase 2 (AK2) 
gene lead to maturation defects in lymphoid and myeloid cells [58].  
 
3.1. Thymic defects — treatment 
Most of these severe primary immunological diseases are commonly treated by 
allogeneic hematopoietic stem cell transplantation (HSCT) or, in some cases, by gene 
therapy with re-infusion of genetically modified autologous hematopoietic cells. 
Instead, thymus transplantation is a therapeutic option for infants with DiGeorge 
Syndrome (22q11.2 deletion syndrome; deletion of genes required for thymus 
development) and Winged helix deficiency (mutation in FOXN1 gene; important for 
thymus development).  
Although, these procedures have been successful in treating some immunodeficiencies, 
but they have not been so in treating diseases affecting multiple organs alongside the 
hematopoietic system. These challenges ask for new approaches to discover treatments 
for rare diseases affecting multiple organs, and individually optimized therapy concepts 
have to be targeted. The target-specific therapeutic agents must be able to trigger 
cellular functions that are enhanced or suppressed to compensate for imbalanced or 
missing functionality of the affected gene. 
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4. The Non-Hematopoietic System 
Hematopoietic cells are also strongly influenced by the surrounding non-hematopoietic 
cells, which consist of tissue-forming cells (fibroblasts, endothelial cells, epithelial cells, 
nerve cells, etc.) that form the environment in which immune responses can occur [59]. 
Not only failures in the hematopoietic system can lead to life-threatening disorders, 
defects in the non-hematopoietic system can also be the cause for a disease.  
In vertebrates, after fertilization, the development of a multicellular organism begins 
from a single-celled zygote [60]. A zygote undergoes rapid cell division to form a 
spherical ball of cells, the blastula. At this stage in mammals, they are called blastocytes 
[60]. The next step in embryonic development is the formation of the gastrula. During 
triploblastic gastrulation, three germ layers, the ectoderm, endoderm and mesoderm 
layers, are formed [60]. Each of these germ layers develops into different organs or 
tissue systems (Figure 3). This involves the coordination of multiple complex 
developmental processes, such as embryonic induction, pattern formation, 
morphogenesis, cell proliferation, and differentiation. 
 
 
Figure 3. The three germ layers during embryogenesis. The three germ layers endoderm, mesoderm and 
ectoderm give rise to all of a vertebrate’s tissues and organs [60]. Figure adapted and adjusted from threesology.org. 
 
4.1. The skin 
The skin is the largest organ of the body. It is a constantly renewing organ that provides 
a protective covering essential for thermal and osmotic regulation in preventing 
unregulated loss of water and solutes. It also functions as an effective barrier between 
an organism and the environment, protecting against invasion by pathogens and 
fending off chemical and physical injuries. The skin consists of two major components: a 
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stratified squamous epithelium and the dermis. The dermis is part of the connective 
tissue and is a highly vascularized region, drained by lymphatic vessels, equipped with 
sensing nerve ends and hair follicles, composed of mesenchymally derived fibroblasts, 
rich in collagen, elastin and fibers, and other components of the extra cellular matrix 
(ECM) (Figure 4) [61]. Draining lymphatics begin in the dermis and traverse the deeper 
layers of the skin to eventually access lymph nodes. An accurate interplay between the 
cells of the epidermis and dermis is needed to establish a proper dermo-epidermal 
architecture, a polarized pattern of epithelial growth, and differentiation of the basal 
layer of proliferating keratinocytes, and the formation of dermal-resident fibroblasts 
[61].  
 
 
Figure 4. Difference in structure and cellular components between mouse and human skin. (a) Mouse skin is 
densely packed with hair follicles and has a thin epidermis. In the epidermis, the most prominent population is 
dendritic epidermal T cells (DETCs). Recruited γδ T cells play an important role in skin immune surveillance and IL-17 
and IL-22 production. (b) The human epidermis has larger areas of interfollicular skin with sparse hair follicles and a 
thick epidermis with more cell layers. The most prevalent immune cells in the epidermis are Langerhans cells and 
CD8+ T cells. In both, mouse and human, the dermis is populated by macrophages, mast cells, conventional αβ T cells, 
and some innate lymphoid cells (ILCs). Figure adapted from [62]. 
 
Skin homeostasis and immunity are mainly controlled by the crosstalk between 
immune cells, vascular endothelial cells, fibroblasts, and keratinocytes. This epidermal-
dermal cell interaction is driven by cytokines, chemokines, antimicrobial peptides 
(AMPs), and growth factors [63, 64]. Many different populations of myeloid and 
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lymphoid immune cells either reside in or traffic into the dermis. These immune cell 
populations are dynamic and change during immune responses.  
 
4.1.1. Keratinocytes 
Skin epidermis can be divided into a viable stratified squamous part and a dead layer — 
the stratum corneum (Figure 5). The latter consists of additional 3 diversified 
layers/strata: (1) stratum basale (basal layer), (2) stratum spinosum (spinous layer), and 
(3) stratum granulosum (granulose layer). The stratum basale, or basal layer, harbors 
proliferative self-renewing cells — rapidly dividing progeny stem cells. These are 
undifferentiated basal keratinocytes that undergo a limited number of divisions — this 
is referred to as transit amplifying [65]. Before keratinocytes withdraw from the cycle to 
become differentiated, they detach from the basement membrane to begin a 
maturation process during which they migrate toward the surface of the skin. 
Keratinocytes in the stratum granulosum are characterized by dark clumps and produce 
keratin proteins and lipids [66]. Keratinocytes that reach the body surface are the 
ultimate product of maturing keratinocytes. These are dead, enucleated, flattened 
keratinocytes (squames) that are subsequently sloughed and are continually replaced 
by inner cells that move outwards. The keratinocytes in this layer are called corneocytes 
and form the outermost layer — the stratum corneum. The stratum corneum builds a 
permeability barrier to prevent excessive water loss and penetration of water-soluble 
substances. Each corneocyte is surrounded by a protein shell called cell envelope. The 
cell envelope is composed of two proteins, loricrin and involucrin. These proteins 
contain extensive links between each other, making the cell envelope the most 
insoluble structure of the corneocytes. Attached to the cell envelope is a layer of 
ceramide lipids that repel the water. Corneocytes are held together by 
corneodesmosomes. The corneal layer is a unique layer to the skin and not present in 
other epithelia (such as in the gut or the lungs).  
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Figure 5. Layers of the dead and viable epidermis. The viable mammalian epidermis is a stratified squamous 
epithelium that can be divided into different cell layers. Resting on the basement membrane is the basal layer (BL) 
consisting of proliferating, transit-amplifying cells (dividing progeny of stem cells). The basal layer stratifies to give 
rise to differentiated cell layers of the spinous layer (SL), granular layer (GL), and a layer containing dead cells — the 
stratum corneum (SC). Figure adapted from [61]. 
 
The stratum corneum and tight junctions within the stratum granulosum ensure an 
effective physical barrier. The corneal layer also provides a scaffold function for 
microflora (antimicrobial activity). Keratinocytes express many pattern-recognition 
receptors, such as functional TLRs and NLRs, which make them able to respond to 
stimulation by pathogens or stress factors, and therefore able to induce immune 
responses [66]. 
In the skin, keratinocytes are an important source of cationic antimicrobial peptides 
(AMPs), such as β-defensins and cathelicidins [67, 68]. In addition to AMPs, keratinocytes 
constitutively secrete, or can be induced to release, a wide range of cytokines, including 
IL-1, IL-6, IL-10, IL-18, IL-33 and TNF-α [69, 70]. Thus, keratinocyte-intrinsic pathways play 
a key role in regulating immune homeostasis and inflammation in the skin. Conversely, 
inflammation does also regulate keratinocyte proliferation [71]. 
 
4.1.2. Fibroblasts and the extracellular matrix (ECM) 
The dermis consists of mesenchymally derived fibroblasts, and a mixed population of 
innate and adaptive immune cells. Fibroblasts are the most common cells that make up 
the structural framework of connective tissues. Fibroblasts are the primary cells that 
build and maintain the ECM [72, 73]. 
Fibroblasts play a pivotal role in regulating the skin physiology, and they are usually 
quiescent and become activated in wound healing processes [74]. Once activated, the 
functions of fibroblasts include synthesizing the extra cellular matrix, generating 
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cytokines and chemokines, recruiting immune cells and exerting physical forces to 
modify tissue architecture [75]. Fibroblasts can produce TNF-α, IL-6, IL-8 and diverse set 
of growth factors, including epidermal growth factor (EGF) and fibroblast growth factors 
(FGFs) [76]. FGFs are polypeptide growth factors with diverse biological activities, and 
induce positive and negative regulation of proliferation, survival, migration, and 
differentiation [77]. For instance, FGF3, FGF7, FGF10 and KGF1 (keratinocyte growth 
factor 1) are known to induce keratinocyte proliferation [78, 79].  
The extracellular matrix is highly conserved among species and is assembled into 
diverse structures depending on the tissue and its particular composition of the ECM 
proteins [80]. The ECM consists of a diverse set of metalloproteinases, growth factors, as 
well as fibrous proteins, such as collagens, elastin, fibronectin, glycosaminoglycans, and 
many others [80]. The ECM is involved in many developmental, physiological and 
pathological processes, including cell proliferation, tissue homeostasis, differentiation, 
cell adhesion and cell migration [81-83]. Cell migration and adhesion are controlled by 
integrins and the components of the ECM [84, 85] (Figure 6). Cell-ECM interactions are 
crucial in angiogenesis and the formation of the cardiovascular system. 
 
  
Figure 6. Components of the extra cellular matrix. The extra cellular matrix is the non-cellular component present 
within in all tissues and organs [86]. For instance, collagen, proteoglycans, fibronectin and other compounds play an 
important role for cell adhesion and migration. Integrins expressed on the cell surface can interact with the ECM 
components to perform motility [84]. 
 
The ECM directs essential morphological organization and physiological function by 
binding growth factors to elicit signal transductions [77]. Consequently, the ECM plays a 
fundamental role in the dermis and other tissues. 
It is the organization of the stromal cell network that provides support for adaptive and 
innate immune cells to drive efficient immune responses. This interdependence of 
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stromal cells of different lineages with all types of hematopoietic cells plays, therefore, 
an integral part in forming skin immunity. Even in healthy tissue, the type of stroma and 
its cellular activity influence its hematopoietic composition. 
 
4.2. Skin disorders 
Numerous skin disorders, such as psoriasis, atopic dermatitis, or contact dermatitis are 
associated with dysregulation of immune responses in the skin.  
 
4.2.1. Psoriasis  
Psoriasis is a chronic lifelong inflammatory skin disease that develops in genetically 
susceptible individuals upon unknown initial environmental, pathogenic, or internal 
triggers. Psoriatic skin is characterized by keratinocyte hyperproliferation, leading to 
thickening of the epidermis (acanthosis), combined with dysregulated keratinocyte 
differentiation resulting in altered protein expression, loss of a mature granular layer 
and retention of keratinocyte nuclei (parakeratosis) (Figure 7). These changes are 
accompanied by increased dermal vascularity and accumulation of inflammatory 
infiltrates of T cells, neutrophils, and macrophages [64]. The immunopathogenesis of 
psoriasis is a close interdependence of the epidermis and dermal inflammatory 
infiltrates, as well as a balance between innate and adaptive immune system. 
By analogy with autoimmune-type diseases, psoriasis has been considered a Th1-type 
disease, where TNF-α, IL-2, and INF-γ play a role [87]. The current view involves Th1, 
Th17 and Th22 cells and proposes a model in which activated dendritic cells and 
macrophages express IL-12 and IL-23, which causes T cells to differentiate toward 
effector cell activity [88-90]. Data from clinical studies and experiments in mouse 
models describe the IL-23/IL-17 axis as the essential pathway in the pathogenesis of 
psoriasis [91-93]. 
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Figure 7. Difference between human and mouse skin. (a) Histological overview of human healthy (left) and 
psoriatic (right) skin (hematoxylin-eosin (H&E) staining; Magnification: x20). Acanthosis (epidermal thickening) is 
accompanied with elongated rete ridges. Hyperkeratosis of the stratum corneum (cornified layer thickening). 
parakeratosis (presence of nuclei in cornified layer) and scales peeling off are shown. The black arrow indicates 
dermal inflammatory infiltrates. (b) Histological features of murine healthy (left) and psoriasis-like (right) skin (H&E; 
Magnification: x20). Acanthosis with elongation of rete-like ridges, hyperkeratosis with microabscesses of 
inflammatory cells (neutrophils), parakeratosis, and scales peeling off are shown. The black arrow indicates dermal 
inflammatory infiltrates. Figure adapted from [94]. 
 
In the Aldara-treated mouse model, it has been shown that formation of psoriatic 
lesions depends on γδ T cells (Vγ4+ TCR) in the absence of Th17 and Th22 cells. These γδ 
T cells together with type 3 innate lymphoid cells (ILC3) are the main source of IL-17A, 
IL-17F and IL-22 [95]. IL-17 regulates antimicrobial peptides (AMPs), whereas IL-22 acts 
on keratinocytes to induce hyperproliferation [96]. Therapeutic studies of psoriasis are 
based on clinical observations in humans [97]. Today, anti-IL17A antibodies and anti-
IL12/23p40 antibodies are used to treat psoriasis [98, 99].  
 
4.2.2.  Atopic Dermatitis 
Atopic Dermatitis (AD) is the most common inflammatory skin disease worldwide. 
Impaired skin barriers with increased trans-epidermal water loss and sensitization to 
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allergens often caused by filaggrin deficiency and Th2/Th22-skewed inflammation are 
critical biological features observed in the majority of patients [100-102]. There is a 
consensus that the leaky epithelial barrier facilitates allergen sensitization and promotes 
exposure to infectious agents [103]. The magnitude of skin barrier dysfunction 
correlates with AD disease severity. Acute AD skin lesions are characterized by 
thickening of the epidermis and dermis, dermal infiltration of CD4+ T cells and 
eosinophils, increased expression of Th2-related cytokines IL-4 and IL-13, and Th22-
related cytokine IL-22. A recent study did focus on the mechanism of cutaneous 
sensitization driven by IL-23-producing dendritic cells in a mouse model with similar 
features to AD. The results describe a novel pathway in which IL-23 released by 
keratinocytes after mechanical skin injury targets skin dendritic cells, up-regulating their 
endogenous IL-23 production and polarizing them to drive an IL-22 response in naïve 
CD4+ T cells, which, in turn, mediates epidermal thickening [104]. An ongoing trial is also 
testing the utility of IL-23 and IL-22 blockade in AD. 
 
5. TTC7A Mutations in Humans 
Mutations in the tetratricopeptide repeat (TPR) domain 7A gene (TTC7A) cause an 
autosomic recessive multi-organ disease. The disease is caused by homozygous or 
compound heterozygous mutations spread along the TTC7A gene localized on 
chromosome 2p21 (Figure 8). TTC7A deficiency is a rare devastating disease where less 
than 50 patients have been described so far. The disorder presents with immune defects 
ranging from severe combined immunodeficiency (SCID) to hypogammaglobulinemia 
and autoimmunity [105-113]. Most patients suffer from MINAT (OMIM #243150), which 
is known as multiple intestinal atresia, or GIDID (OMIM #243150), which stands for 
gastrointestinal defects and immunodeficiency syndrome. In some cases, patients 
present with a very early onset inflammatory bowel disease (VEOIBD), and enteropathy-
lymphocytopenia-alopecia (ELA) syndrome have been described [105, 107-114]. 
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Figure 8. Overview of all known homozygous disease causing mutations in TTC7A deficiencies. The TTC7A 
crystal structure was predicted based on the available structure of TTC7B (over 95% structural similarity). The C- and 
N-terminus are given in black capital letters. The position of amino acids affecting disease-causing mutations is given 
in small black letters and described below the protein structure. “*” = stop codon, “fs*” = frame shift lead to stop 
codon. This figure was drawn in collaboration with Prof. Sebastian Hiller, Biozentrum, Basel. 
 
Overall, the gut is the most affected organ — ranging from intestinal atresia at birth to 
inflammatory bowel disease. Despite successful hematopoietic stem cell 
transplantation in combination with surgical outcomes in patients with atresia are often 
poor. Unfortunately, the ongoing progression of gastrointestinal disease can be life-
threatening. This observation indicates that the loss of TTC7A function does not only 
affect immune homeostasis but also the stromal compartment. Epithelial cell-intrinsic 
effects have been suspected to link TTC7A mutations with disrupted apicobasal polarity 
of the intestinal epithelium. Pathological examination of gut biopsies from TTC7A-
deficient patients affirmed an inverted enterocyte polarity in patient-derived gut 
organoid cultures [107, 108].  
 
5.1. Spontaneous gene mutations in murine Ttc7  
Based on gene homology, three mouse strains are known and commercially available, 
carrying spontaneously occurring mutations in Ttc7, the orthologous gene to TTC7A in 
humans. Ttc7 is localized on chromosome 17 and contains 20 exons. The hereditary 
erythroblastic anemia (hea) mutant mouse (Ttc7hea/hea) carries a large deletion of exons 
1–14 in Ttc7. The mutation is inherited in an autosomal recessive manner. Affected 
homozygous Ttc7hea/hea mice have hematological abnormalities, a severe anemia since 
birth, and die at around 1 week of age [115]. An atrophic thymus and defective T-cell 
differentiation during thymocyte development have been reported [116]. The mutation 
in homozygous Ttc7jic/jic mice is caused by a genomic in-frame deletion, resulting in two 
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different but equally produced amplicons. Transcript 1 is missing exons 9 to 10, and 
transcript 2 lost exons 9 to 11. Ttc7hea/hea and Ttc7jic/jic  mice show a similar phenotype, but 
Ttc7jic/jic mice have a longer life expectancy and die at around 2 weeks of age [117]. The 
flaky skin (fsn) mutant mouse (Ttc7fsn/fsn) bears an insertion of an endogenous retrovirus-
like element (ETn) between exons 14 and 15 [118]. This 183bp-long element leads to an 
enlarged protein of 858 amino acids. Studies using Ttc7fsn/fsn mice have focused on 
immunological dysfunction and autoimmunity [119-122]. We therefore decided to work 
with the flaky skin mutant mouse model, which results in a life expectancy of 3 months. 
 
5.2. Flaky skin (fsn) mutant mouse model – Ttc7fsn/fsn 
In contrast to humans with intestinal disease, fsn mutant mice develop a severe 
hyperplastic dermatitis as the main feature associated with pleiotropic abnormalities, 
including a hyperproliferative immune disorder (splenomegaly and lymphadenopathy), 
gastric forestomach papillomas, anemia and autoimmunity [119, 121, 123-128]. The 
autoimmunity is presented by a hyperactivation of CD22Low B cells (immature B cells) in 
the spleen, including a fraction of autoreactive B-1 cells [129]. This expansion and 
activation of autoreactive plasma cells leads to the production of circulating antinuclear 
autoantibodies, which is likely associated with a chronic IL-4 exposure. An 
overproduction of IL-4 has been described in hyperactivated splenic lymphocytes due 
to constitutive STAT6 activation, hyperresponsiveness to IL-2, IL-4, and IL-7, and 
enhanced IgE production in responses to ovalbumine [121].  
The Ttc7fsn/fsn mouse has been regarded as a model for human psoriasis because of 
patchy, thick, white scales on the skin with microscopically evident acanthosis, 
parakeratosis and hyperkeratosis, mononuclear dermal infiltrates with increased 
amount of mast cells, and dilation of dermal capillaries [125-127].  
The Ttc7fsn/fsn mouse strain shows some immune-related phenotypes that resemble those 
in humans with mutations in TTC7A. A study comparing the skin of patients with TTC7A 
mutations and that of Ttc7fsn/fsn mice reported on clinical, functional, and 
histopathological findings consistent with abnormal epidermal maturation and 
epidermal barrier dysfunction [130].  
However, the Ttc7 mutation in the flaky skin mutant mouse differs from the ones 
described in TTC7A in humans. The Ttc7 mutation is based on an insertion, which 
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disrupts a tetratricopeptide repeat (TPR) domain. TPR-motifs are known to mediate 
protein–protein interactions and are essential for multi-protein complexes [131]. The 
mutation leads to reduced levels of wild-type transcripts. Ttc7 is expressed in many 
different tissues. Microarray analysis of mouse tissues has shown similar relative levels of 
Ttc7 expression in bone marrow, lymph nodes, and various T and B cell subsets [117, 
127]. 
 
6. TTC7 is a scaffold protein — A chaperone 
TTC7 is ubiquitously expressed and functions as a scaffold protein known to play an 
essential role in localizing phosphatidylinositol 4-Kinase-IIIα (PI4KIIIα) to the inner leaflet 
of the plasma membrane [132]. PI4KIIIα is responsible for localization-specific 
phosphorylation of the hydroxyl group at the 4th position of the inositol ring to generate 
the most abundant monophosphorylated phosphatidylinositol 4-phosphates (PI4P). In 
the assembly, TTC7 plays a central role in bridging PI4KIIIα to EFR3B (membrane-
resident anchor protein) and FAM126A, via direct interaction (similar to human TTC7A 
and TTC7B) (Figure 9A); this results in PI4P synthesis at the plasma membrane [133].  
 
 
Figure 9A. TTC7 act as scaffold protein in bridging PI4KIIIα  to EFR3B at the plasma membrane via binding to 
FAM126. PI4KIIIα phosphorylates phosphatidylinositol (PI) at the 4th position of its inositol ring to generate 
phosphatidylinositol 4-phosphate (PtdIns4P = PI4P). EFR3 — palmitoylated resident anchor protein (red), FAM126 
(blue), PI4KIIIα (turquois), and TTC7 (green). Figure adapted from [133]. 
 
PI4P is the metabolic precursor of phosphatidylinositol 4,5-biphosphate (PI(4,5)P2), the 
major substrate for receptor-linked phospholipase C and phosphatidylinositol 3-kinase 
(PI3K), and thereby it is essential in regulating a variety of signaling pathways in 
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different cell types. Furthermore, PI(4,5)P2 plays a general role in actin polymerization at 
the plasma membrane, vesicular trafficking (endocytosis/exocytosis), cell motility, the 
formation of the immunological synapse, and other cellular processes [134-138] (Figure 
9B).  
 
 
Figure 9B. Roles of PI(4,5)P2 at the plasma membrane. (B) Examples of cellular processes regulated by PI(4,5)P2 (= 
PtdIns(4,5)P2) at the plasma membrane. PLC = phospholipase C; ECM = extracellular matrix. Figure adapted from 
[139]. 
 
Further synthesis of phosphoinositides have been widely implicated in receptor 
signalling and as anchors for structural proteins, therefore controlling a wide range of 
cellular processes, including cytokinesis, cell polarization, migration, adhesion, 
formation of the lamellipodium for cell motility, and morphogenesis [139]. The synthesis 
and turnover of phosphoinositides are spatially and temporally tightly regulated 
processes [21]. Dysfunctions in the control of the phosphoinositide levels often lead to 
pathologies [139]. 
 
6.1. TTC7A deficiency — a primary immunodeficiency combined 
with multisystemic disease 
 
Genetic diseases with multisystemic outcomes, such as seen in TTC7A deficiencies, 
require a deeper understanding of the leading mediator(s) and mechanisms involved 
the pathogenesis of the disease. Dissecting the effect that a genetic mutation has on 
multiple-organs requires studies of each system separately. 
Until now, it has not been clear whether the disease results primarily from intrinsic T cell 
defects, thymic epithelial defects, or both. Thus, the value of HSCT in patients carrying 
TTC7A mutations is subject to debate. Mouse models are of great benefit to study such 
multisystemic diseases. 
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The flaky skin mutant mouse model presents a multifactorial disorder with a striking 
hyperplastic skin phenotype. The overview of the pathophysiology of the flaky skin 
mutant mouse is still elusive. We do not know whether an intrinsic epidermal-barrier 
dysfunction is the initial insult that precedes dysregulated immune activation or if 
altered immune activation leads to reactive epidermal hyperplasia.  
Considering the multisystemic disease in patients and the flaky skin mutant mouse with 
an evident skin pathology, we aimed to study the skin in different mouse strains 
carrying the flaky skin mutation with the focus to investigate whether cells of non-
hematopoietic or hematopoietic origin trigger the development of the hyperplastic skin 
phenotype. 
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IV. MATERIAL and METHODS 
1. Animals 
All mouse experiments were performed in accordance with the Swiss Federal 
Veterinarian Office and Cantonal Veterinary Office guidelines. 
 
1.1. The flaky skin mutant mouse – Ttc7fsn/fsn 
BALB/cBy.A-fsn/+ mice (termed Ttc7fsn/+, CD45.2) were obtained from The Jackson 
Laboratory (Bar Harbor, ME, USA) and maintained under specific pathogen-free 
conditions at the Laboratory Animal Services Center (University of Zurich, Zürich, 
Switzerland). Given that neither female nor male Ttc7fsn/fsn mice will mate, heterozygous 
Ttc7fsn/+ mice were used to obtain wild-types (WT), heterozygous and homozygous 
mutant flaky skin mice for experiments. The mice used in these experiments were 2- to 
14-weeks old. All mice were maintained and handled in accordance with Swiss Federal 
Veterinarian Office and Cantonal Veterinary office guidelines. The presence of the flaky 
skin was confirmed by a restriction site analysis of the PCR products of mouse ear DNA. 
Briefly, a punched sample (diameter: 1.5mm) from the mouse ear was incubated at 55°C 
in a lysis reagent (catalog 31-402-E) (Peqlab, VWR, Erlangen, Germany) containing 
proteinase K (0.2mg/mL) (catalog P4850) (Sigma Aldrich) for 5 to 16h. Proteinase K was 
inactivated by incubation at 85°C for 45 min. The resulting DNA-containing solution was 
then directly used for PCR assays with the following primers: WT: 5’-
GAAGAGCAGCGCTAGCAAGT-3’; forward Ttc7: 5’-CAA GATGCTTGCTTCTGG-3’; reverse 
ETn: 5’-CCGATACGAAGATCCTTTCC-3’ (94°C for 3min; 94°C for 30sec, 60°C for 30sec, 
73°C for 45sec, 73°C for 5min; x40). The DNA samples were separated on a 1.5% agarose 
gel containing SYBR® Safe DNA Gel Stain (Invitrogen by Thermo Scientific) DNA from WT 
mice produced a single 450bp band only for the WT-DNA strain, DNA from Ttc7fsn/fsn mice 
produced a single 450bp band only for the mutant-DNA strain, and DNA from 
heterozygous mice produced a single 450bp band for the WT-DNA strain and a single 
450bp band for the mutant-DNA strain. 
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1.2. Ly5.1 Balb/c mice  
CBy.SJL(B6)-Ptprc<a>/J (Balb/c; CD45.1) mice were purchased from The Jackson 
Laboratory and used as controls for adoptive hematopoietic stem cell transfer (license 
No. 65/2014).  
 
1.3. Rag2-deficient and Rag2-IL2rg-deficient mice  
The C.129S7-Rag2<tm1Mom> (Rag2-/-; Balb/c; CD45.2) mice and the Balb/c-
IL2rg<tm1>B6.129S6-Rag2<tm1Fwa> (IL2rg-/-, Rag2-/-; CD45.2) mice were a generous gift 
from Professor Burkhard Becher (University of Zurich). These mice were crossed with 
Ttc7fsn/+ mice for the generation of the double and triple homozygous mutant mice. The 
offspring of double and triple homozygotes were genotyped by using the following 
primer combinations. For the Rag2-knockout, the following primer combination was 
used: forward primer Rag1 5’-GGG AGG ACA CTC ACT TGC CAG TA-3’, Rag2 5’-AGTC 
AGG AGT CTC CAT CTC ACT GA-3’ and reverse Ragneo 5’-CGG CCG GAG AAC CTG CGT 
GCAA-3’ (94°C for 3min; 94°C for 30sec, 55°C for 30sec, 72°C for 45sec, 72°C for 5min; 
35x; WT: 263bp, mut: 350bp).  
The primer combinations for IL2rg-knockout were as follows: forward primer P5 5’-CCT 
GCG TGC AAT CCA TCT TGT TCA AT-3’, reverse primer P7: 5’-
CTGCTCAGAATGCCTCCAATTCC-3’, and primer pNeo: 5’-CCT GCG TGC AAT CCA TCT TGT 
TCA AT-3’ (94°C for 3min; 94°C for 30sec, 55°C for 30sec, 72°C for 45sec, 72°C for 5min; 
35x; WT: 650bp, mut: 400bp).  
All mice used in subsequent experiments were identified by genotyping with the 
specific primer combinations listed above. 
 
2. Hematopoietic Stem Cell Transfer (HSCT) 
2.1. Bone marrow isolation 
Femur, tibia and fibula were collected from CO2 euthanized mice and stored in PBS. 
Bone marrow was flushed with a 29G syringe and 1x phosphate buffer saline (PBS) 
(Gibco by Life TechnologiesTM) supplemented with 2% fetal bovine serum (FBS, heat-
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inactivated) (Sigma Aldrich) and 2.5mM EDTA (Sigma Aldrich). Whole bone marrow – 
Lin- and Lin+ cells – were purified with PBS and counted with Neubauer Improved 
chips, disposable hemocytometer (C-Chip, NanoEnTek). Bone marrow chimeras were 
generated by transplanting fresh 5 x 106 wild-type (Balb/c CD45.2) or 5 x 106 Ttc7fsn/fsn 
(Balb/c CD45.2) cells sampled from whole bone marrow. Cells were stored in an 
appropriate volume of sodium chloride solution (0.9%, B. Braun Medical AG) prior to 
tail-vein injection.  
 
2.2. Irradiation 
Mixed Lin- and Lin+ bone marrow cells were injected intravenously (i.v.) into total-body-
irradiated female wild-type CD45.1–congenic host mice (Balb/c) receiving two 400 rad 
doses with a 24h inter-dose interval (225kV, 17.7mA) (RS-2000, Rad Source 
Technologies, Inc.). Bone marrow chimeric mice were allowed to reconstitute for 10 to 
12 weeks without further treatment. Irradiated mice received a 1:250 dilution of 24% 
Borgal in their drinking water for 14 days. 
 
3. Organ and Tissue Preparation 
Mice were euthanized by CO2 inhalation. Peripheral blood was immediately collected by 
cardiac puncture and kept in EDTA-coated tubes under rotation at room temperature 
(K2E BD Microcontainer, BD BiosciencesTM). Thymus, axillary and inguinal lymph nodes, 
spleen, skin (shaved areas) and gastrointestinal tract were isolated and stored in cold 1x 
phosphate buffer saline (PBS) (Gibco by Life TechnologiesTM) supplemented with 2% 
fetal bovine serum (FBS) (Sigma Aldrich).  
 
3.1. Histopathology  
For histopathologic examination tissues (thymus, spleen, axillary and inguinal lymph 
nodes, skin, and gastrointestinal tracts – forestomach, duodenum, and colon) were fixed 
in 4% paraformaldehyde and embedded, following standard protocols. Deparaffinized 
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sections were stained with hematoxylin-eosin reagent according to standard protocols. 
Further, immunohistochemical stainings with anti-CD45/LCA (30-F11, 1:150, BD 
Bioscience), anti-CD3 (Rabbit Mab RMAB 005, 1:150, Diagnostic Biosystems), anti-CD4 
(4SM95, 1:150, eBioscienceTM), anti-CD19 (pY531, 1:150, Abcam), anti-B220 (RA3-6B2, 
1:150, BD Biosciences), anti-IL-17 (ab79056, 1:150, Abcam), anti-IL-22 (NB100-738, 1:150, 
Novus Biologicals, Biotechne brand), and anti-CD11c (HL3, 1:150, BD Biosciences) 
according to manufacturer’s instructions were performed followed by counterstaining 
with hematoxylin and a BONDTM Bond Polymer Refine Detection Kit (Leica Biosystems, 
Newcastle, United Kingdom). The images were acquired with a bright field light 
microscope (Zeiss Axio Observer, Carl Zeiss AG, Switzerland) at a magnification of 5x or 
10x. 
 
4. Flow Cytometry 
4.1. Cell preparation  
4.1.1. Thymus, spleen, skin-draining lymph nodes 
Single-cell suspensions were prepared from thymus, spleens, and skin-draining lymph 
nodes (axillary, brachial and inguinal lymph nodes = pLN). Thymus, spleen, and lymph 
nodes were harvested, cut into small pieces, and digested in Hank’s Balanced Salt 
Solution (Ca+2, Mg+2, HBSS) (Gibco byLife TechnologiesTM) supplemented with 10% fetal 
bovine serum (FBS) (Sigma Aldrich), 0.2U/mL Liberase TM (Roche Applied Science), and 
0.1mg/mL DNAse (Roche Applied Science) for 5 – 10min at 37°C. Afterwards, the tissue 
fragments were passed through a 40µm wire mesh. Erythrocytes in splenocyte and 
lymph node cell suspensions were lysed with Red Blood Cell Lysis buffer (Sigma Aldrich) 
for 2min at room temperature. Purified cells were then counted prior to antibody 
staining for flow cytometry analyses.  
 
4.1.2. Skin 
For leukocyte isolation fat tissue and hair were removed from skin, cut into small pieces, 
and digested in an enzymatic cocktail consisting of 10% FBS (Sigma Aldrich), 0.25U/mL 
Liberase DL (Roche Applied Science), and 0.1mg/mL DNAse (Roche) added to HBSS 
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(Ca+2, Mg+2) (Gibco by Invitrogen) for 2h at 37°C with repetitive pipetting to disrupt skin 
architecture. The tissue fragments were then passed through a 40µm wire mesh and 
purified. The cell suspension was magnetically labeled with CD45 MicroBeads (MACS, 
Miltenyi Biotec, Bergisch Galdbach, Germany), loaded onto a MACS column, and 
separated into CD45negtive and CD45positive fractions (MACS, Miltenyi Biotec). Collected 
CD45positive cells were purified and blocked with anti-mouse CD16/32 (93; TruStain fcXTM, 
BioLegend) prior to antibody staining for flow cytometry analyses.  
 
4.2. Staining antibodies 
For surface and intracellular staining, the following dyes and fluorochrome-coupled 
antibodies were used at saturating concentrations: Zombie Aqua (amine reactive-
fluorescent dye for live/dead stain, BioLegend; 1:100), rat anti-mouse Per-CP-anti-
CD45.1 (A20; BioLegend; 1:50), APC-anti-CD45.1 (A20; BioLegend; 1:50), Pacific-Blue-
anti-CD45.2 (104; BioLegend; 1:50), PE/Cy7-anti-CD19 (6D5; 1:50, BioLegend), Alexa-
Fluor-700-anti-CD3 (17A2; BioLegend; 1:50), FITC-anti-CD4 (GK1.1; eBioscience; 1:50), PE-
anti-CD8a (53-6.7; eBioscience; 1:50), FITC-anti-CD11b (M1/70; BioLegend; 1:50), PE-anti-
Ly6G (1A8; BioLegend; 1:50), APC-Cy7-anti-Ly6C (HK1.4; BioLegend; 1:50), primary 
Biotin-anti-Siglec F antibody (MACS, Miltenyi Biotec; 1:10), in combination with 
secondary Alexa-Fluor-700-Streptavidin antibody (MACS, Miltenyi Biotec; 1:200), and 
APC-anti-F4/80 (BM8; BioLegend: 1:50). Measurements were performed using a Gallios 
flow cytometer (Beckman Coulter), and the data were analyzed with Flow Jo software 
(Version 10.2, Graphpad Software). 
 
4.3. Blood — Hemogram  
4.3.1. Blood  
Peripheral blood was immediately collected after CO2 asphyxation from mice by cardiac 
puncture and kept in EDTA-coated tubes (K2E BD Microcontainer, BD Pharmingen). 
Blood samples were then filtered through 70μm nylon wire mesh and diluted with 1x 
PBS in a 1:5 ratio. Blood counts were performed using the ADVIA 120 Hematology 
System (Siemens).  
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4.3.2. Serum cytokines 
Peripheral blood was collected into regular 1.5mL Eppendorf tubes post mortem by 
cardiac puncture from mice. Blood samples were left for 30 – 60min at room 
temperature for blood coagulation. Then, the samples were centrifuged at 3,000rpm 
(1500 x g) for 20min at room temperature. The supernatant (serum) was carefully 
transferred into new Eppendorf tubes and prepared for multiplex assay analysis or 
stored at -80°C. 
 
4.3.3. Multiplex assay technology combined with flow cytometry analysis 
After spinning color-coded beads pre-coated with analyte-specific capture antibodies 
for IL-2, IL-4, IL-5, IL-6, IL-10, IL-15, IL-17, IL-22, EPO, TNF-α,  TGF-β and IFN-γ kit (Bead-Kits 
from Luminex, ProcartaPlex) were used to measure serum cytokine levels using a Guava 
EasyCyte flow cytometer (Merck Millipore).  
 
5. Organoid Culture 
5.1. Three-dimensional intestinal organoid cultures of the gastro-
intestinal tract (GI) 
Organoids of small intestine, stomach corpus and forestomach were established from 
freshly isolated glands from each organ. Incubation in 1x PBS (ph 7.4) containing 2mM 
EDTA (from the small intestine) or 5mM EDTA (for the stomach and colon) was used for 
the isolation of glands. Biopsy specimens were manually dissected, and the mucosal 
layer was cut into small pieces that were washed, embedded in Matrigel (BD 
Biosciences), and cultured in conditions, as previously described [140].  
 
6. Next Generation Sequencing (NGS) 
6.1. Primary fibroblast cell culture 
RNA was isolated from primary mouse fibroblast cultures from wild-type and Ttc7fsn/fsn 
mice. From shaved back skin fatty tissue and hairs were carefully removed under sterile 
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conditions. After cutting the skin into small pieces, the dermal side of the skin was 
attached on cell culture plates. After adherence, skin pieces were covered and cultured 
in Dulbecco's Modified Eagle Medium (DMEM, Gibco by Life TechnologiesTM) 
supplemented with 15% FBS (Gibco by Life TechnologiesTM), 1% sodium pyruvate (Gibco 
by Life TechnologiesTM), 1% Glutamax (Gibco by Life TechnologiesTM), 1% non-essential 
amino acids (Gibco by Life TechnologiesTM), 2mM stable glutamine (Gibco by Life 
TechnologiesTM), 1% Kanamycin (Gibco by Life TechnologiesTM), 5mg gentamicin (Gibco 
by Life TechnologiesTM), and 1x Anti-Anti (Gibco by Life TechnologiesTM). After 14 days 
primary fibroblast culture plates were flushed with 1x PBS and directly lysed and stored 
in TRIzol Reagent (Ambion by Life TechnologiesTM). Total RNA was isolated using a 
PureLink RNA Mini Kit (Invitrogen by Life TechnologiesTM) according to the 
manufacturer’s instructions. 
 
6.2. NGS of RNA from Ttc7fsn/fsn and wild-type fibroblasts  
Next generation sequencing (NGS) of purified total RNA isolated from fibroblasts from 
wild-type and Ttc7fsn/fsn mice was performed by the Functional Genomic Center Zurich 
(ETH Zurich and University of Zurich, Zurich, Switzerland).  
NGS of purified total RNA isolated from Fibroblast of wild-type in triplicates and Ttc7fsn/fsn 
mice in quadruplicates were performed by the Functional Genomic Center Zurich. The 
TruSeq stranded mRNA Sample Prep Kit (Illumina, Inc, California, USA) was used with a 
starting amount of 500ng total RNA per sample [141]. Libraries were sequenced on 
HiSeq4000 in single read mode at 1x125 bp and NGS reads were quality-checked with 
FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). Reads were 
trimmed with Trimmomatic (v0.33, 4 bases hard-trimming from the start, and adapter 
trimming at the end) [141]. We aligned the trimmed reads to the reference genome and 
transcriptome (FASTA and GTF files, respectively, Ensembl GRCm38) with STAR version 
2.5.1b [142]. Gene expression was quantified using RSEM (version 1.2.22) [143].  To 
detect differentially expressed genes, we applied the count based negative binomial 
model implemented in the R/Bioconductor package edgeR (R version: 3.3.2, edgeR 
version: 3.16.5), in which the normalization factor was calculated by the trimmed mean 
of M values (TMM) method [144, 145]. 
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The unsupervised hierarchical cluster analysis of RNA-seq data is based on normalized 
counts after log transformation with an offset of 10 counts added. The 2,500 genes with 
the biggest variance across all samples were used. 
 
6.2.1. MetaCoreTM 
The NGS data was studied and quantified by using analytical MetaCoreTM tools for 
functional analysis. MetaCoreTM is based on a high-quality, manually-curated database 
of transcription factors, receptors, ligand, kinases, drugs, and endogenous metabolites 
and other molecular classes. Signaling and metabolic pathways were represented in 
tables and maps. 
 
7. Dermal-Epidermal Skin Substitute (DESS) 
7.1. Primary mouse fibroblast cell culture  
To isolate fibroblasts, mouse skin samples were cut into small (1cm2) pieces and 
digested overnight at 4°C in 12U/ml Dispase (Corning). Next, the dermis and the 
epidermis were separated using a forceps. The dermal compartment was further 
digested with 2mg/ml collagenase for 1h at 37°C. Isolated fibroblasts were then seeded 
on tissue culture plates and grown in Dulbecco's Modified Eagle Medium (DMEM) 
(Gibco by Invitrogen) supplemented with 10% FBS, 1% HEPES, and 5mg/mL gentamicin. 
 
7.2. Primary human keratinocyte cell culture  
To isolate human keratinocytes, foreskin samples were cut into small (1cm2) pieces and 
digested overnight at 4°C in 12U/ml Dispase (Corning). Afterwards, the dermis was 
separated from the epidermis using forceps. The epidermal compartment of the skin 
was further digested in 0.5% trypsin (Gibco by Invitrogen) for 2min at 37°C. Isolated 
keratinocytes were cultured in serum-free medium (CellnTec) supplemented with 
25mg/mL bovine pituitary extract, 0.2ng/mL epidermal growth factor, and 5mg/mL 
gentamicin. 
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7.2.1. Preparation of DESS containing skin fibroblasts isolated from 
Ttc7fsn/fsn and wild-type mice.  
The DESSs were prepared using 3ml of bovine collagen type I (5mg/mL, Symatese 
Biomateriaux) mixed with 2 x 105 mouse fibroblasts isolated from Ttc7fsn/fsn (Ttc7fsn/fsn 
DESS) or wild-type skin (WT DESS) and cultured in six-well cell culture inserts (pore size: 
3.0μm; BD Biosciences, Allschwil, Switzerland). The prepared dermal equivalents were 
cultured in DMEM (Gibco, Invitrogen, Carlsbad, USA) supplemented with 10% FBS, 1% 
HEPES, and 5mg/mL gentamicin for 7 days following seeding of 7 x 105 keratinocytes 
isolated from human foreskin and DESS were cultured for five addition days and 
subsequently transplanted onto immunocompromised rats (athymic nude rats, 
Foxn1rnu/rnu). 
 
7.3. Transplantation of DESS  
The surgical protocol was approved by the local Committee for Experimental Animal 
Research (authorization number: ZH090/15). Immunocompromised female nude rats 
aged eight to ten weeks (Harlan Laboratories) were prepared and anesthetized as 
previously described [146]. DESSs were transplanted into full-thickness skin wounds 
created surgically on the animal’s back. The protection from wound closure was 
provided by suturing steel surgical rings (diameter: 26mm) to the skin defects using 
non-absorbable polyester sutures (Ethibond®; Ethicon). The DESSs were covered with 
silicon foil (Silon-SES; BMS), a polyurethane sponge (Ligasano, Ligameda bandage 
(Sincohaft, Theo Frey AG), and tape as a wound dressing. Photographs were taken 
weekly when the wound dressing was changed. Three weeks after the transplantation, 
the DESSs were excised and processed for cryosection analysis. 
 
7.4. Immunofluorescence staining of transplanted DESS  
12µm cryosections were fixed with 1:1 acetone/methanol for 5min at -20°C, air-dried, 
washed three times in PBS, blocked in 2% bovine serum albumin in PBS solution for 
30min, and incubated overnight at 4°C with diluted primary antibodies. Thereafter, 
slides were washed three times in PBS, blocked for an additional 15min, and incubated 
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with an appropriate secondary antibody for 45min at room temperature. Lastly, the 
slides were incubated for 5min in PBS containing 1µg/ml Hoechst reagent (Sigma 
Aldrich), washed once using PBS, mounted with mounting medium (Dako, Baar, 
Switzerland), and covered with coverslips. Immunofluorescence pictures were taken 
using a DXM1200F digital camera connected to a Nikon Eclipse TE2000-U inverted 
microscope equipped with Hoechst 33342-, Fluorescein Isothiocyanate (FITC)-, and 
Tetramethylrhodamine Isothiocyanate (TRITC)-filter sets (Nikon AG; Software: Nikon 
ACT-1 version 2.70). Images were processed with Photoshop software (version 10.0, 
Adobe Systems, Inc.). The following primary antibodies were used: anti-loricrin 
(polyclonal, 1:200, Abcam), Alexa Fluor 488 anti-E-cadherin (clone 67A4, 1:50, BD 
Pharmingen), and anti-Ki67 (clone SP6, 1:100, Abcam).  
 
7.4.1. Quantification of cell proliferation in DESS in vivo  
Transplanted skin grafts were stained with an anti-Ki-67 antibody. The number of Ki-67 
positive cells in the basal cell layer was quantified in three separate areas of two 
representative sections from each DESS. The results were analyzed using GraphPrism6 
software and expressed as the mean ± SD count. 
 
8. Statistics  
A clinical monitoring score sheet was used to rate disease severity. Differences between 
two groups or two datasets were examined for statistical significance by using unpaired 
two-tailed Student’s t test. Data were quoted as the mean ± standard deviation (SD). 
The correlation between two parameters was estimated by calculating Pearson’s r. 
Statistical significance was expressed as follows: *p<0.05, **p<0.01, ***p<0.001, ns: not 
significant, and nd: not detected. All statistical analyses were performed with Prism 
Software (Version 6, GraphPad Software, Inc). 
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9. Data availability  
Sequence data that support the findings of this study have been deposited in the 
European Nucleotide Archive with the primary accession ID PRJEB21496. The authors 
declare that all other data supporting the results of this study are available on request. 
 
10. Study approval  
Human keratinocytes were isolated from foreskin samples from children 1 – 16 years of 
age. This part of the study was performed in accordance with the tenets of the 
Declaration of Helsinki and after approval by the local investigational review board of 
the ethics commission in Canton Zurich, Switzerland. Parents and/or patients were 
provided with information about the study and gave their written consent. All animal 
experiments were approved by the Cantonal Veterinary Office (Zurich, Switzerland; 
approval number: 65/2014). 
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V. RESULTS 
 
1. Phenotype of the fsn mutant (Ttc7fsn/fsn) mouse 
 
1.1. Anemia 
In previous studies on the homozygous fsn mutant mouse, a hypochromic microcytic 
anemia has been described, which is obvious at birth and becomes more severe with 
increasing age [123, 127]. The anemia is the most probable reason why the Ttc7fsn/fsn mice 
die at the age of 12 to 14 weeks. We measured red blood cells counts and hemoglobin 
content in Ttc7fsn/fsn mice and could confirm these findings (Figures 10A, 10B). 
Additionally, we measured serum levels of erythropoietin (EPO). This glycoprotein 
hormone is synthesized by the kidney-resident fibroblasts and fetal liver and promotes 
the survival, proliferation, and differentiation of erythrocytic progenitors of red blood 
cells. Synthesis of EPO relies on a feedback mechanism based on tissue O2 pressure, 
which depends, among other factors, on hemoglobin concentration and iron availability 
[147]. Ttc7fsn/fsn mice have the unique ability to excrete elevated levels of iron through the 
urine [123, 148]. We observed significantly higher serum EPO levels, which increased with 
age in Ttc7fsn/fsn mice when compared with WT littermates (Figure 10C), consistent with 
an iron-deficient anemia. Taken together, anemia in Ttc7fsn/fsn mice is based on elevated 
urinary iron excretion, pointing out an altered epithelial function of renal tubular cells. 
This is associated with increased EPO concentrations in blood. 
 
 
Figure 10. Decreased RBC counts and HGB levels are accompanied by elevated serum EPO levels in Ttc7fsn/fsn 
mice. (A and B) Red blood cell (RBC) counts and hemoglobin (HGB) levels in peripheral blood of gender-matched wild-
type (WT) and Ttc7fsn/fsn mice at the age of 10 weeks. (C) Serum erythropoietin (EPO) levels measured in 2- and 10-week 
old WT and Ttc7fsn/fsn mice. Scatter plots indicate pooled data with average mean ± standard deviation (SD) from >3 
independent experiments. Each symbol represents one individual mouse (n = 6–10). 
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1.2. Splenomegaly 
Another hallmark of the flaky skin mutant mouse is the hyperplasia of the spleen [128]. 
We assessed the severity of the splenomegaly relative to body weight at different ages of 
the mice. Spleens of Ttc7fsn/fsn mice were not enlarged compared to wild-type littermates 
at 2 weeks, but with increasing age, the splenomegaly became apparent (Figures 11A, 
11B).  
 
 
Figure 11A-B. Splenomegaly aggravates with increasing age. (A) Photos of spleens from female WT and Ttc7fsn/fsn 
mice at the age of 2, 4 and 10 weeks. (B) Spleen to body weight ratios. (A) Photos are representative of 3–4 
independent experiments. (B) Scatter plots indicate pooled data with average mean ±SD from 3–4 independent 
experiments. Each symbol represents one individual mouse (n = 3–5).  
 
Histopathology revealed enlarged red pulp in spleens from Ttc7fsn/fsn mice at 4 and 10 
weeks, when compared with age-matched WT littermates (Figures 11C, 11D). This 
observation was accompanied by higher numbers proliferating Ki-67 positive cells 
(Figure 11E) and a higher number of total splenocytes (Figure 11F).  
 
 
Figure 11C-F. Enlarged red pulp and higher numbers of proliferating splenocytes in Ttc7fsn/fsn mice. (C) 
Hematoxylin-eosin staining of splenic sections from 4- and 10-week old female WT and Ttc7fsn/fsn mice (Magnification: 
x5). White and black scale bars correspond to 100μm; “W” = white pulp; “R” = red pulp. (D) Immunohistochemical 
stainings of splenic sections with anti-CD20 and anti-CD3 antibodies in 10-week old WT and Ttc7fsn/fsn mice 
(Magnification: x5). White and black scale bars correspond to 100μm. (E) Immunohistochemical staining of splenic 
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sections with anti-Ki-67 antibodies from 10-week old wild-type and Ttc7fsn/fsn mice (Magnification: x20). White and black 
scale bars correspond to 50μm. Representative microscopic images of >3 independent experiments. (F) Total 
splenocyte numbers of 4- and 10-week old WT and Ttc7fsn/fsn mice quantified by flow cytometry. Each symbol of the 
scatter plot represents one individual mouse (n = 6–8); mean ±SD from >3 independent experiments are indicated. 
 
In order to analyze what cells the spleens consist of, we performed further measurements 
by flow cytometry. We found mainly an increased number of cells deriving from the 
erythroid lineage (data not shown). However, we also observed a significantly higher 
number of CD45-positive cells (a leukocyte-common antigen) in Ttc7fsn/fsn spleens when 
compared with spleens from WT littermates (Figure 11H). CD19+ B cells were lower in 
frequency, but the total number did not differ between Ttc7fsn/fsn and WT mice (Figures 
11G, 11I). Instead, we found a decreased frequency and total number of CD3+ T cells in 
Ttc7fsn/fsn mice (Figures 11G, 11J). Within in this cell group, CD4+ T cells were lower in 
frequency and total numbers, and CD8+ T cells were lower in frequency but similar in total 
numbers compared to wild-type littermates (Figures 11K-M). Overall, the lymphocyte 
cell counts did not significantly differ between Ttc7fsn/fsn and WT spleens. These 
observations are consistent with previous publications [119, 121, 128].  
 
 
Figure 11G-M. The spleens of Ttc7fsn/fsn mice contain more leukocytes but similar total numbers of B and T cells. 
(G) Representative flow cytometric dot plots of CD19+ B cells (CD19+/CD45+ cells) and CD3+ T cells (CD3+/CD45+ cells) in 
spleens of 10-week old female WT and Ttc7fsn/fsn mice. (H) Total number of CD45+ cells, (I) CD19+ B cells, and (J) CD3+ T 
cells. (K) Representative flow cytometric dot plots of CD4+ (CD3+CD4+/CD45+ cells) and CD8+ T cells (CD3+CD8+/CD45+ 
cells) in spleens of WT and Ttc7fsn/fsn mice. (L) Total number of CD4+ T cells and (M) CD8+ T cells. (H-J, L-M) The bars 
indicate pooled data as the mean +SD from >3 independent experiments (n = 8–12 mice). 
 
In contrast to the equal numbers of lymphocytes, the myeloid cell compartment in 
spleens of Ttc7fsn/fsn mice significantly differed between Ttc7fsn/fsn and WT spleens; higher 
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frequencies and total numbers of eosinophils, neutrophils, and monocytes were found 
(Figures 11N-P). Interestingly, some Ttc7fsn/fsn mice showed a higher frequency of 
CD11bLow macrophages whereas other mutants had higher frequencies in CD11bHigh 
macrophages, but in total, the numbers of these two macrophage populations were not 
significantly different compared to the wild-type numbers (Figure 11Q). The severity of 
the anemia in Ttc7fsn/fsn mice can differ. Macrophages tightly control the production and 
clearance of red blood cells during healthy and disturbed erythropoiesis [149]. An 
increased clearance of apoptotic cells in the Ttc7fsn/fsn mice could explain the elevated 
numbers of CD11bHigh and CD11bLow macrophages that we observe in the spleen of these 
mice.  
 
 
Figure 11N-Q. Increased numbers of eosinophils, neutrophils, and monocytes in Ttc7fsn/fsn mice. (N-Q) 
Representative flow cytometric dot plots of eosinophils, neutrophils, monocytes, and macrophages in spleens of 10- 
week old female WT and Ttc7fsn/fsn mice. (N) Eosinophils (CD11b+, Siglec F+ and SS-HHi/CD45+), (O) neutrophils (CD11b+, 
Ly6G+/CD45+ Siglec F+ and SS-HHi), (P) monocytes (CD11b+, Ly6C+/CD45+ Siglec F+ SS-HHi and Ly6G+), (Q) CD11bLow 
macrophages (CD11bLow, F4/80+/CD45+ Siglec F+ SS-HHi Ly6G+ and Ly6C+), and CD11bHi macrophages (CD11bHi, 
F4/80+/CD45+ Siglec F+ SS-HHi Ly6G+ and Ly6C+) are given as total number per lymph node of the indicated gate. The 
bars represent pooled data as the mean +SD from >3 independent experiments (n = 8–12 mice).  
 
In mice, the spleen plays a crucial role in erythropoiesis outside the bone marrow, even in 
healthy adult animals. Extramedullar production, particularly in the spleen, is part of the 
physiological erythropoiesis. Under erythroid stress conditions, such as iron deficiency, 
the spleen is used to expand the erythropoietic capacity, which takes place in an 
impressive way in the Ttc7fsn/fsn mice. Red blood cells accumulate in the red pulp 
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compartment and lead to severe splenomegaly, as has been described in the literature. 
Correspondingly, our findings led us to conclude that we could reconfirm published data, 
revealing hyperplasia of the spleen, because of greatly increased red pulp due to 
accumulation of immature erythroid cells characterizing the anemia [119, 123, 127].  
 
1.3. Axillary, brachial and inguinal lymphadenopathy 
All major epithelial barriers of the body, including the skin, as well as the gastrointestinal 
and bronchial mucosa, have their own system of lymph nodes. The axillary, brachial and 
inguinal lymph nodes are important skin-draining lymph nodes. They play a major role in 
activating immune responses in the Ttc7fsn/fsn mouse. The work of Abernethy and Pelsue 
shows histological and immunological data on lymph node alterations observed in 
Ttc7fsn/fsn mice [119, 128, 150]. Based on these publications, we wanted to ascertain at 
which age these abnormalities initially develop. We assessed the extent of 
lymphadenopathy at ages of 2, 4, and 10 weeks. On a macroscopic level, the Ttc7fsn/fsn 
mice only showed slight differences in lymph nodes size at the age of 2 weeks when 
compared with littermates as a control (Figure 12A). This difference in size and weight 
progresses with age. The differences become more evident at the age of 4 weeks and 
even more conspicuous at the age of 10 weeks  (Figures 12A, 12B).  
 
 
Figure 12A-B. Lymphadenopathy in Ttc7fsn/fsn mice. (A) Photos of axillary lymph nodes from female WT and Ttc7fsn/fsn 
mice at the age of 2, 4 and 10 weeks. (B) Skin-draining lymph node (pLN = axillary, brachial and inguinal LN) weight at 
the age of 2, 4, and 10 weeks. (A) Photos are representative of three independent experiments. (B) Scatter plots indicate 
pooled data as the mean ±SD from 3–4 independent experiments. Each symbol represents one individual mouse (n = 
5).  
 
The histopathological and immunohistochemical analysis of the skin-draining lymph 
nodes revealed medullary and cortical regions containing higher cell counts, thus 
indicating that there is a tendency of increased proliferation present in flaky skin mutant 
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mice when compared to age matched controls  (Figures 12C-E). With increasing age, a 
reduction of the follicular and enlargement of the cortical area became apparent. 
 
 
Figure 12C-F. Hyperplasia of skin-draining lymph nodes accompanied by increasing cellularity with age. (C) 
Hematoxylin-eosin staining of lymph node sections from 4- and 10-week old female WT and Ttc7fsn/fsn mice 
(Magnification: x5). White and black scale bars represent 100μm; “F” = follicle; “C” = Cortex. (D) Immunohistochemical 
stainings of lymph node sections with anti-CD20 and anti-CD3 antibodies of 10-week old wild-type and Ttc7fsn/fsn mice 
(Magnification: x5). White and black scale bars correspond to 100μm. (E) Total cell numbers per lymph node in 4- and 
10-week old WT and Ttc7fsn/fsn mice.  (F) Immunohistochemical staining of lymph node sections with anti-Ki-67 antibody 
from 10-week old WT and Ttc7fsn/fsn mice (Magnification: x20). White and black scale bars correspond to 50μm. (C, D, F) 
Representative microscopic images of >3 independent experiments. (E) Each symbol of the scatter plot represents one 
individual mouse (n = 6–7) and visualizes cumulative data with average mean ±SD from >3 independent experiments.  
 
Based on this observation, we characterized the distribution of immune cells by flow 
cytometric analysis in 10-week old female Ttc7fsn/fsn mice. We observed a significant 
increase in total numbers of CD45-positive cells. Amongst these CD45+ cells, the 
frequency and total number of CD19+ B cells were elevated. Furthermore, when 
quantifying CD3+ T cells, that were subdivided into CD4+ and CD8+ T cells, higher total 
numbers were present in the Ttc7fsn/fsn mice when compared to controls (Figures 12J-M). 
Also the Ttc7fsn/fsn mice had proportionally more CD8+ than CD4+ T cells in their lymph 
nodes. Consequently, the CD4+/CD8+ ratio was remarkably reduced in Ttc7fsn/fsn mice (0.78 
± 0.16, mean ±SD) compared to WT mice (3.02 ± 0.86, mean ±SD). This result was 
consistent with a previous publication [128].  
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Figure 12G-M. The skin-draining lymph nodes of Ttc7fsn/fsn mice are filled predominately with CD8+ T cells. (G) 
Representative flow cytometric dot plots of CD19+ B cells and CD3+ T cells in skin-draining lymph nodes of 10-week old 
female WT and Ttc7fsn/fsn mice. (H) Total number of CD45+ cells (CD45+/Alive), (I) CD19+ B cells (CD19+/CD45+), and (J) 
CD3+ T cells (CD3+/CD45+). (K) Representative flow cytometric dot plots of CD4+ and CD8+ T cells in lymph nodes of WT 
and Ttc7fsn/fsn mice. (L) Total number of CD4+ T cells (CD4+/CD45+CD3+) and (M) CD8+ T cells (CD8+/CD45+CD3+) per 
lymph node. (H-J, L-M) Bar plots indicate pooled data from >3 independent experiments as the mean +SD (n = 10 
mice). 
 
 
Figure 12N-Q. Lymphadenopathy is also associated with increased numbers of eosinophils, neutrophils, 
monocytes, and macrophages in Ttc7fsn/fsn mice. (N-Q) Representative flow cytometric dot plots of eosinophils, 
neutrophils, monocytes, and macrophages in skin-draining lymph nodes of 10-week old female WT and Ttc7fsn/fsn mice. 
(N) Eosinophils (CD11b+, Siglec F+ and SS-HHi/CD45+), (O) neutrophills (CD11b+, Ly6G+/CD45+ Siglec F+ and SS-HHi), (P) 
monocytes (CD11b+, Ly6C+/CD45+ Siglec F+ SS-HHi and Ly6G+), (Q) CD11bLow macrophages (CD11bLow, F4/80+/CD45+ 
Siglec F+ SS-HHi Ly6G+ and Ly6C+), and CD11bHi macrophages (CD11bHi, F4/80+/CD45+ Siglec F+ SS-HHi Ly6G+ and Ly6C+) 
given as total number per lymph node of the indicated gate. (N-Q) Bar plots represent pooled data from >3 
independent experiments as the mean +SD (n = 10 mice).  
 
In the myeloid-derived cell compartment, both the frequencies and total numbers of 
eosinophils, neutrophils, monocytes, and macrophages were increased (Figures 12N-Q). 
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Overall, these results show that cells of the lymphoid and myeloid lineage both 
contribute to hyperplasia of the skin-draining lymph nodes, but they do not disrupt the 
lymph node architecture in Ttc7fsn/fsn mice. 
 
1.4. Premature thymic atrophy 
The thymus is a primary lymphoid organ that undergoes dynamic physiological changes 
with age and is additionally very sensitive to stress and toxic injury. The intrathymic 
maturation of T cells consists of several phases that require the dynamic relocation of 
maturing lymphocytes within multiple architectural structures. As part of this process, the 
thymocytes interact with specialized thymic epithelial cells. Our next aim was to clarify 
whether the thymic development is disturbed in Ttc7fsn/fsn mice. We assessed thymi of 
female Ttc7fsn/fsn mice and WT mice at the ages of 2, 4, and 10 weeks. At 2 weeks of age, 
there were no differences in size or total thymocyte numbers and the cortical and 
medullary architecture was normal (Figures 13A, 13B). In contrast, the thymi of 4-week 
old Ttc7fsn/fsn mice were macroscopically smaller in size and lower in weight, although the 
intrathymic architecture (Figure 13A) and thymocyte numbers were comparable to 
controls (Figures 13B-13D). A reduced number of thymocytes in Ttc7fsn/fsn mice was 
present at the age of 10 weeks (Figures 13C, 13D). At this age, histological analysis 
revealed a vague cortico-medullar demarcation and a seeming expansion of the 
medullary region in Ttc7fsn/fsn mice (Figure 13A). 
 
 
Figure 13. Thymic vague cortico-medullary demarcation accompanied by fewer thymocytes in 10-week old 
Ttc7fsn/fsn mice. (A) Hematoxylin-eosin staining of thymus sections from 2-, 4-, and 10-week old female WT and Ttc7fsn/fsn 
mice (Magnification: x5). White and black scale bars correspond to 100μm; “M” = Medulla; “C” = Cortex. (B) Total 
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thymocyte numbers of 2-, 4-, and 10-week old WT and Ttc7fsn/fsn mice. (C) Representative photos of 4- and 10-week old 
WT and Ttc7fsn/fsn mice. (D) Corresponding thymus weight of WT and Ttc7fsn/fsn mice. (B and D) Each symbol of the scatter 
plot represents one individual mouse (n = 4–12) and visualizes cumulative data with average mean ±SD from >3 
independent experiments.  
 
These results indicate that a premature thymic atrophy is present, which could possibly 
be due to an accelerated conventional aging process. One could hypothesize that this 
was accelerated by an intrinsic defect in thymic stromal cells, whereupon thymocyte 
development could have been affected. 
 
1.5. Gastric forestomach papillomas 
Previous publications have shown that forestomach papillomas can have various triggers 
that can include chemical compounds, dietary changes, viral, fungal or parasite infections 
[151]. In the Ttc7fsn/fsn mouse, forestomach papillomas occurred spontaneously [151]. We 
similarly observed these hyperplastic changes of forestomach epithelial cells in Ttc7fsn/fsn 
mice (Figures 14A, 14B). The formation of papillomas was already evident at the age of 2 
weeks (data not shown). Based on data published by Lemoine and colleagues, describing 
disrupted apicobasal enterocyte polarity in human patients carrying mutations in TTC7A, 
we sought to determine whether the small and large intestine of the Ttc7fsn/fsn mouse 
shows similar abnormalities [108]. Thus, 3-dimensional epithelial “organoid” cultures of 
the small intestine and the stomach, from Ttc7fsn/fsn mice and WT littermates, were 
established. The forestomach papillomas grew as large clumps with a disturbed epithelial 
cell polarity (Figure 14C). While the Ttc7fsn/fsn organoids of the small intestine displayed a 
normal epithelial architecture with a correctly organized cell polarization pattern, the 
Ttc7fsn/fsn stomach corpus formed organoids with a disturbed architecture. While the 
lumen was present, the organoid did not display and crypt-villus domains (Figure 14D).  
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Figure 14. Organoids of gastro-intestinal (GI) tract: gastric forestomach papillomas and normal small intestine 
formation in Ttc7fsn/fsn mice. (A) Representative macro- and microscopical photos of forestomach papillomas of 10-
week old female Ttc7fsn/fsn mice in comparison with WT littermates. (B) Hematoxylin-eosin staining of forestomach 
sections from WT and Ttc7fsn/fsn mice (Magnification: x10). Black scale bars correspond to 100μm. (C) Representative 
photos of forestomach papilloma organoid cultures at a magnification of 4x. (D) Representative photos of organoids of 
the small intestine and the stomach corpus from WT and Ttc7fsn/fsn mice (Magnification: x4 and x10). (E) Intestinal 
architecture scheme adapted from [152]. 
 
1.5.1. Duodenum and colon 
Most patients carrying mutations in TTC7A suffer from multiple intestinal atresias and/or 
inflammatory bowel disease (OMIM #243150). Therefore, we examined the small and 
large intestines of Ttc7fsn/fsn mice. We were not able to find any signs of alterations in the 
gut. The length of small intestines and colon, which are known to be reduced in 
inflammatory bowel disease, did not differ between Ttc7fsn/fsn mice and WT littermates. 
Ttc7fsn/fsn mice displayed a normal intestinal architecture, as evidenced by histological and 
immunohistochemical analyses of duodenal and colonic sections (Figures 15A-D). We 
could not observe any infiltration of inflammatory immune cells or elevated numbers of 
apoptotic enterocytes in Ttc7fsn/fsn mice. 
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Figure 15. Duodenum and colon develop normally in Ttc7fsn/fsn mice. (A) Hematoxylin-eosin (H&E) staining of 
duodenum sections from 10-week old female WT and Ttc7fsn/fsn mice (Magnification: x10). Black scale bars correspond to 
100μm. (B) H&E and immunohistochemical stainings with anti-CD3 antibodies of duodenum sections of 10-week old 
WT and Ttc7fsn/fsn mice (Magnification: x20). Black scale bars correspond to 50μm. (C) H&E staining of colon sections from 
10-week old female WT and Ttc7fsn/fsn mice (Magnification: x10). Black scale bars correspond to 100μm. (D) H&E and 
Immunohistochemical stainings with anti-CD3 antibody of colon sections of 10-week old WT and Ttc7fsn/fsn mice 
(Magnification: x20). Black scale bars correspond to 50μm. 
 
1.6. Hyperplastic dermatitis 
Ttc7fsn/fsn mice present with a severe hyperplastic dermatitis as the main feature of their 
complex phenotype [126]. Ruffled fur and thick, white, patchy scales are visible from the 
age of 6–8 weeks onwards.  
 
Scheme for skin classification and quantification: 
 
Figure 16A: Skin Scheme for classification and quantification. Back skin sections of female wild-type and Ttc7fsn/fsn 
mice at 10 weeks stained with hematoxylin-eosin reagent (Magnification: x20). Black scale bars correspond to 50μm. 
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Hyperkeratosis (thickening of the stratum corneum (sc) – dead epidermis) with ablation of keratin scales at the 
surface (right black arrow) in combination with parakeratosis depicting preserved nuclei (left black arrow). Acanthosis 
corresponds to thickening of the viable epidermis (stratum ganulosum (sg) and stratum spinosum (ss)) (indicated by 
black arrowheads) between stratum corneum (sc) and stratum basale (sb) with elongation of rete-like ridges. 
Mononuclear dermal infiltrates (black retangle – DI). 
 
 
 
Histological analysis of skin sections revealed acanthosis (thickening of the viable 
epidermis), hyperkeratosis, and dermal infiltrates by leukocytes beginning at 4 weeks of 
age (Figure 17A).  
 
 
Figure 17A. Early onset of hyperplastic dermatitis in Ttc7fsn/fsn mice. (A) Back skin sections of female WT and Ttc7fsn/fsn 
mice at the age of 4 and 10 weeks stained with hematoxylin-eosin reagent (Magnification: x10). Black scale bars 
represent 50μm. Acanthosis corresponds to thickening of the viable epidermis (black arrowheads) and hyperkeratosis 
showing thickening of the dead epidermis with ablation of keratin scales at the surface of the stratum corneum (black 
arrows). 
 
Based on the age-related worsening of skin lesions, we quantified the severity of the 
lesions in both 4- and 10-week old mice. When comparing 4-week-old mice with 10-week 
old mice, the difference in dermal infiltration between Ttc7fsn/fsn mice and WT littermates 
was more pronounced than the difference in the severity of acanthosis (Figures 17B-E); 
this implies that acanthosis had occurred before dermal inflammation.  
Figure 16B. Distinction between dermal infiltrates. The black rectangle 
depicts mast cells found in the dermis of Ttc7fsn/fsn mice. They can be 
distinguished from other granulocytes by their clear formation of granules 
stained by the hematoxylin-eosing reagent. The black arrow depicts a 
mononuclear cell in the dermis. 
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Figure 17B-E. Hyperplastic dermatitis gets more severe with age. (B) Quantification of acanthosis in WT and 
Ttc7fsn/fsn in three different visual fields (each of which was divided into five quadrants) per mouse. (Objective lens 
magnification: x10). Each symbol on the scatter plot represents the mean ±SD of 15 stratum spinosum thickness 
measurements in an individual mouse. (C) Hyperkeratosis of the stratum corneum was quantified by rating the severity 
per mouse. Grade 0: one or two peeled-off corneal layers at the surface; Grade 1: two or three peeled-off corneal layers; 
Grade 2: four or more peeled-off corneal layers. Each symbol represents the mean grade from three different pictures 
per mouse in each group. (E) Inflammation of the dermis was quantified by counting the total number of inflammatory 
cell infiltrates in the dermis underneath the basal layer. Three different images per mouse dermis (Magnification: x40) 
were captured and printed as 13x18 cm photos for evaluation. The symbols represent the mean number of cell 
infiltrates per mouse in each group. (E) Numbers of mast cells having infiltrated the dermis. The number of mast cells is 
included in the number of dermal cell infiltrates. Three different images per mouse dermis (Magnification: x40) were 
captured and printed as 13x18 cm photos for evaluation. Each symbol represents the mean mast cell count per mouse 
in each group. Each symbol in the scatter plots corresponds to an individual mouse (n = 5 mice), mean ±SD are 
indicated.  
 
To characterize dermal leukocytes, we performed immunohistochemical staining of skin 
sections for lymphoid and myeloid markers. These stainings revealed high numbers of 
cells expressing CD4 and IL-17 (Figures 17F-H). 
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Figure 17F-H. Most dermal infiltrates belong to the lymphoid cell fraction in Ttc7fsn/fsn skin. (F) Skin sections 
stained with anti-CD45, anti-CD3, (G) anti-CD4 and anti-IL-17 antibodies of female WT and Ttc7fsn/fsn mice at the age of 
10 weeks (Magnification: x10). Black scale bars correspond to 50μm. (H) Skin sections of female WT and Ttc7fsn/fsn mice at 
the age of 10 weeks stained with anti-MPO and anti-CD11c antibodies (Magnification: x10). Black scale bars correspond 
to 100μm. 
 
1.7. Serum cytokine profile 
Welner and colleagues showed that isolated splenic T cells from Ttc7fsn/fsn mice 
spontaneously produced high amounts of IL-4 [121]. Others correspondingly described 
higher serum levels of IL-5 [119]. To determine the possible effectors of hyperplasia and 
immune cell infiltration in the skin, we measured serum levels of cytokines known to be 
involved in inflammatory skin diseases, such as psoriasis or atopic dermatitis [153-155]. 
The serum levels of IL-4, IL-5, IL-10, IL-17 and IL-22 were significantly higher in Ttc7fsn/fsn 
mice than in WT littermates (Figures 18A, 18B). In both strains, levels of IFN-γ and TNF-α 
were apparently below the corresponding assay’s limit of detection, while IL-15 and TGF-
β levels were measurable but did not show significant differences between the two 
mouse strains (data not shown).  
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Figure 18. Serum cytokine profiles. (A) Serum cytokine levels of IL-4, IL-5, IL-6, IL-10 and TNF-α in 4-and 10-week old 
WT and Ttc7fsn/fsn mice. (B) Serum cytokine levels of IL-17 and IL-22 in 10-week old WT and Ttc7fsn/fsn mice. Cytokine 
profiles were measured in serum of gender-matched mice. Bars indicate pooled data from >3 independent 
experiments as the mean +SD (n = 6–11 mice).  
 
Cytokines can modulate the proliferation of keratinocytes; this has been shown for IL4/IL-
13 in atopic dermatitis and for the IL-23/IL-17 axis in psoriatic mouse models, in in vitro 
analysis and clinical studies [91, 154]. A high proportion of cells in Ttc7fsn/fsn skin sections 
stained positive for IL-17. Together with elevated serum IL-17 levels, this suggests that 
Th2 and Th17 cells promote the flaky skin phenotype. 
 
Taking into account the ubiquitous expression of Ttc7 and the multisystemic nature of 
the disease seen in both patients and Ttc7fsn/fsn mice — both developing an epithelial 
barrier dysfunction — we decided to further analyze the impact of hematopoietic and 
stromal cells on the hyperproliferative skin phenotype seen in the Ttc7fsn/fsn mouse.  
 
2. Double and Triple Homozygous Mutant Mice 
First, we generated immunodeficient double homozygous Rag2-/-Ttc7fsn/fsn and triple 
homozygous Rag2-/-IL2rg-/-Ttc7fsn/fsn mutant mice and assessed their pathophysiology. The 
double mutant lacks lymphocytes from the adaptive immune system, whereas the triple 
mutant lacks lymphocytes from both the adaptive and innate immune system. 
 
 
2.1. Splenomegaly associated with anemia 
Double (Rag2-/-Ttc7fsn/fsn) and triple (Rag2-/-IL2rg-/-Ttc7fsn/fsn) mutant strains presented with a 
severe anemia with low red blood cell counts and low hemoglobin levels (Figures 19A, 
19B). The spleens were enlarged resulting in a 3–4-fold increase of the spleen/body 
weight ratio in mutant strains (Figures 19C, 19D). Histopathologic analysis of the spleen 
showed enlarged red pulp areas in spleens of double and triple mutant mice when 
compared with WT mice (Figure 19E). 
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Figure 19A-E. Splenomegaly and anemia are preserved in double and triple mutant mice. (A) Red blood cells 
(RBC) and (B) hemoglobin (HGB) counts in peripheral blood of WT, single (Ttc7fsn/fsn), double (Rag2-/-Ttc7fsn/fsn), and triple 
(Rag2-/-IL2rg-/-Ttc7fsn/fsn) mutant mice at 10 weeks. (C) Photos of spleens from female WT, single, double, and triple 
mutant mice. (D) Spleen to body weight ratios. (E) Hematoxylin-eosin staining of splenic sections from double and 
triple mutant mice (Magnification: x5). White scale bars represent 100μm. “R” = red pulp. (A, B, D) The genotype of each 
mouse is shown below the chart (WT = wild-type, FSN = Ttc7fsn/fsn, Rag2 = Rag2-/- (KO), IL2rg = IL2rg-/- (KO)). Scatter plots 
indicate pooled data as the mean ±SD from >3 independent experiments. Each symbol represents one individual 
mouse (n = 8–12 mice).  
 
Further flow cytometric analysis of the spleens showed higher total numbers of 
splenocytes in double and triple mutant mice (Figure 19F). Despite higher CD45-positive 
cell counts, we did not find an increase in total numbers of any myeloid cell types in 
double nor in triple mutant mice when compared to the corresponding controls (Figures 
19G-K). The increase in CD45-positive cells resulted from an increase in cells of the 
erythroid lineage (data not shown). 
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Figure 19F-K. Equal total numbers of eosinophils, neutrophils, monocytes, and macrophages in double and 
triple mutant mice. (F) Total number of splenocytes of 10-week old female WT, single, double, and triple mutant mice. 
(G) Total number of CD45+ cells (CD45+/Alive). (H) Eosinophils (CD11b+, Siglec F+ and SS-HHi/CD45+), (I) neutrophils 
(CD11b+, Ly6G+/CD45+ Siglec F+ and SS-HHi), (J) monocytes (CD11b+, Ly6C+/CD45+ Siglec F+ SS-HHi and Ly6G+), (K) 
CD11bLow macrophages (CD11bLow, F4/80+/CD45+ Siglec F+ SS-HHi Ly6G+ and Ly6C+), and CD11bHi macrophages 
(CD11bHi, F4/80+/CD45+ Siglec F+ SS-HHi Ly6G+ and Ly6C+) indicated as the total number per spleen. (F-K) The genotype 
of each mouse is shown below the chart (WT = wild-type, FSN = Ttc7fsn/fsn, Rag2 = Rag2-/- (KO), IL2rg = IL2rg-/- (KO)). Bars 
indicate pooled data from >3 independent experiments as the mean +SD (n = 8–12 mice).  
 
2.2. Hyperplastic skin-draining lymph nodes 
The skin-draining lymph nodes in double and triple mutant strains were smaller than in 
single mutant mice but still remarkably larger than in the Rag2-/- and Rag2-/-IL2rg-/- mice, in 
which lymph nodes cannot be seen macroscopically. (Figure 20A).  
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Figure 20. Non-lymphoid cells are markedly expanded in skin-draining lymph nodes. (A) Representative photos of 
axillary lymph nodes from 10-week old female mice. (B) Axillary lymph node sections of double and triple mutant mice 
stained with hematoxylin-eosin reagent and anti-CD45 antibodies (Magnification: x5). Black scale bars represent 
100μm. (C) Total cell count per skin-draining lymph node. (D) Eosinophils (CD11b+, Siglec F+ and SS-HHi/CD45+), (E) 
neutrophils (CD11b+ and Ly6G+/CD45+ Siglec F+ and SS-HHi), (F) monocytes (CD11b+ and Ly6C+/CD45+ Siglec F+ SS-HHi 
and Ly6G+), (G) CD11bLow macrophages (CD11bLow and F4/80+/CD45+ Siglec F+ SS-HHi Ly6G+ and Ly6C+), and CD11bHi 
macrophages (CD11bHi and F4/80+/CD45+ Siglec F+ SS-HHi Ly6G+ and Ly6C+) given as total numbers per lymph node of 
indicated gates. The genotype is indicated below the chart (WT = wild-type, FSN = Ttc7fsn/fsn, Rag2 = Rag2-/- (KO), IL2rg = 
IL2rg-/- (KO)). Bars represent pooled data as the mean +SD (n = 7–16 mice).  
 
In double and triple mutant mice, the skin-draining lymph nodes were filled with 
nucleated cells that stained positive for CD45 (Figure 20B). The total number of cells per 
lymph node was proportional to the organ size (Figure 20C). Absolute eosinophil, 
neutrophil, monocyte, and macrophage counts were elevated in double and triple 
mutant mice, relative to the corresponding controls (Figures 20D-G). In contrast to the 
high proportion of CD11bLow macrophages seen in single (Ttc7fsn/fsn) mutant mice, the 
lymph nodes of double and triple mutant mice showed markedly elevated levels of 
CD11bHi macrophages; these probably corresponded to tissue-resident anti-inflammatory 
M2 macrophages. Overall, eosinophils, neutrophils, monocytes, and macrophages 
accounted for the main cell populations in skin-draining lymph nodes of the double and 
triple mutant mice. 
 RESULTS 
! 63 
2.3. Spontaneous formation of forestomach papillomas  
Double and triple mutant mice also developed forestomach papillomas (Figures 21A, 
21B). Interestingly, this intrinsic epithelial dysregulation persisted in the epithelium of 
the forestomach of the mutant strains.  
 
 
Figure 21. Spontaneous formation of forestomach papillomas is preserved in double and triple mutant strains. 
(A) Representative macro- and microscopic photos of forestomach papillomas from 10-week old female double and 
triple mutant mice. (B) Hematoxylin-eosin staining of forestomach sections (Magnification: x10). Black scale bars 
correspond to 100μm. 
 
2.4. Hyperproliferative skin is linked with increased IL-22 but 
not IL-17 production 
To attain further insights into the role of Ttc7fsn/fsn lymphocytes in the development of the 
flaky skin phenotype, we next compared the skin phenotypes of double and triple 
mutant strains. Both groups developed ruffled fur and white scaly skin. Interestingly, we 
found IL-22-positive cells not only in the dermis of double mutant mice but also in triple 
mutant mice (Figure 22A). 
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Figure 22. Diffuse epidermal hyperplasia of the skin remains even without systemic IL-17 hypercytokinemia in 
the triple mutant strains. (A) Back skin sections of gender-matched double and triple mutant mice stained with 
hematoxylin-eosin reagent, anti-IL22 antibodies and anti-IL-17 antibodies (Magnification: x10). Black scale bars 
represent to 50μm. Acanthosis (black arrowheads) and hyperkeratosis with ablation of keratin scales at the surface 
(black arrows). (B-E) Quantification of acanthosis (B), hyperkeratosis (C), inflammation of the dermis by total number of 
infiltrates (D), and the number of mast cells in the dermis (E), (Strategy is described under Figures 17B-E). (F) Serum 
cytokine levels of IL-17 and IL-22 in gender-matched WT, single, double and triple mutant mice serum. (B-E) The 
genotype is indicated below the chart (WT = wild-type, FSN = Ttc7fsn/fsn, Rag2 = Rag2-/- (KO), IL2rg = IL2rg-/- (KO)).  Bars 
indicate pooled data from >3 independent experiments as the mean +SD (n = 8 mice). Each symbol in the scatter plots 
corresponds to an individual mouse (n = 5) and expresses the mean ±SD values.  
 
We then quantified the histological changes of the skin (Figures 22B-E). Severity for all 
parameters was significantly altered in all three mutant strains when compared to WT 
mice. Notably though, the double and triple mutant mice showed reduced severity 
grades compared to the single mutant mice in all parameters, except hyperkeratosis. To 
determine possible effectors causing hyperplasia and immune cell infiltration in the skin, 
we measured IL-17 and IL-22. Strikingly, serum IL-17 levels were similar between double 
mutant mice and corresponding controls, but significantly elevated serum IL-22 levels 
were observed in both the double and triple mutants (Figure 22F). Interestingly, the 
highest IL-22 serum levels were measured in the triple mutant mice. This indicates that 
neither T cells, B cells, NK cells nor other innate lymphocytes (ILCs) are the essential 
sources of IL-22 in this murine mutant model. Mast cells predominantly stained positive 
for IL-22 in immunohistochemical assessments (Figure 22A). IFN-γ levels were below the 
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detection limit, and TGF-β levels were equal between mutant strains and the 
corresponding controls (data not shown).  
Collectively, these results suggest that the hematopoietic system is not critical in 
inducing the flaky skin phenotype, although lymphocytes aggravate the clinical course of 
the disease. 
 
3. Bone Marrow Chimera 
In order to determine the influence of mutated hematopoietic cells in causing the 
hyperplastic skin of the flaky skin mutant model, we generated gender-matched bone 
marrow chimeras. The mean level of chimerism 84 days after bone marrow transfer was 
67.5% (range: 40-95%). 
Unfortunately, we were not able to perform an efficient bone marrow transfer of wild-
type cells into Ttc7fsn/fsn mice. These mice died within few days after the transfer, most 
probably due to the pre-existing anemia.  
 
3.1. Slight anemia but no splenomegaly in bone marrow chimera 
Initially, we examined whether the anemia can be transferred leading to hyperplasia of 
the spleen. We did indeed measure slightly reduced red blood cell counts in mice having 
received Ttc7fsn/fsn bone marrow (Ttc7fsn/fsn > WT) (Figures 23A, 23B). However, Ttc7fsn/fsn > 
WT chimeras had equal spleen sizes and spleen/body weight ratios when compared to 
control chimeras (WT > WT) (Figures 23C, 23D). 
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Figure 23A-E. No sign of splenomegaly in Ttc7fsn/fsn  > WT chimera mice. (A) Red blood cells (RBC) and (B) 
hemoglobin (HGB) counts in peripheral blood of WT > WT and Ttc7fsn/fsn > WT chimera mice. (C) Representative photos of 
spleens from female WT, Ttc7fsn/fsn, WT > WT, and Ttc7fsn/fsn > WT mice. (D) Spleen to body weight ratios. (E) Hematoxylin-
eosin staining of splenic sections from WT > WT and Ttc7fsn/fsn > WT chimera mice (magnification: x5). White scale bars 
represent 100μm. “W” = white pulp;  “R” = red pulp. (A, B, D) The genotype of each mouse is shown below the chart (WT 
= wild-type, FSN = Ttc7fsn/fsn). Scatter plots indicate pooled data the mean ±SD from >3 independent experiments. Each 
symbol represents one individual mouse (n = 10–14).  
 
Histopathologic analysis showed normal splenic architecture (Figure 23E). This data was 
consistent with the results from flow cytometric analysis, revealing no difference in 
splenocyte numbers (Figure 23F).  
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Figure 23F-K. No difference in lymphoid cells numbers. (F) Total number of splenocytes in WT, Ttc7fsn/fsn, WT > WT, 
and Ttc7fsn/fsn > WT chimera mice. (G) Total number of CD45+ cells (CD45+/Alive). (H) Total number of CD19+ B cells 
(CD19+/CD45+). (I) Total number of CD3+ T cells (CD3+/CD45+). (J) Total number of CD4+ T cells (CD4+/CD45+CD3+). (J) 
Total number of CD8+ T cells (CD8+/CD45+CD3+). (F-K) The genotype of each mouse is shown below the chart (WT = 
wild-type, FSN = Ttc7fsn/fsn). Bars indicate pooled data from >3 independent experiments as the mean +SD (n = 7–12 
mice).  
 
The lymphoid and myeloid cell counts were similar when comparing the two chimera 
strains (Figures 23G-P).  
 
 
Figure 23L-P. No difference in myeloid cell numbers. (L) Eosinophils (CD11b+, Siglec F+ and SS-HHi/CD45+), (M) 
neutrophils (CD11b+, Ly6G+/CD45+ Siglec F+ and SS-HHi), (N) monocytes (CD11b+, Ly6C+/CD45+ Siglec F+ SS-HHi and 
Ly6G+), (O) CD11bLow macrophages (CD11bLow, F4/80+/CD45+ Siglec F+ SS-HHi Ly6G+ and Ly6C+), and (P) CD11bHi 
macrophages (CD11bHi, F4/80+/CD45+ Siglec F+ SS-HHi Ly6G+ and Ly6C+) indicated as the total number per spleen. (L-P) 
The genotype of each mouse is shown below the chart (WT = wild-type, FSN = Ttc7fsn/fsn). Bars indicate pooled data from 
>3 independent experiments as the mean +SD (n = 8–12 mice).  
 
In summary, although we observed a slight reduction of the red blood cell count after 
transplant of Ttc7fsn/fsn bone marrow, there was no transfer of the other parameters 
indicative of severe anemia via bone marrow transplant. 
 
3.2. No peripheral lymphadenopathy 
Skin-draining lymph nodes of Ttc7fsn/fsn > WT chimera mice had a normal lymph node size 
and correctly organized architecture (Figures 24A, 24B). Both chimera strains gathered 
an equal number of cells in their skin-draining lymph nodes (Figure 24C). Also, flow 
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cytometric analysis of the lymphoid and myeloid cell fraction did not show any 
significant alterations (Figures 24D-L).  
Taking these findings together, there was no transfer of the hyperplastic Ttc7fsn/fsn 
phenotype to the Ttc7fsn/fsn > WT chimera lymph nodes.  
 
 
 
Figure 24. No lymphadenopathy in Ttc7fsn/fsn chimera mice. (A) Representative photos of axillary lymph nodes from 
WT, Ttc7fsn/fsn, WT > WT, and Ttc7fsn/fsn > WT mice. (B) Axillary lymph node sections of WT > WT and Ttc7fsn/fsn > WT chimera 
mice stained with hematoxylin-eosin reagent (Magnification: x5). Black scale bars represent 100μm. F = follicle; C= 
cortex. (C) Total CD45+ cell number per skin-draining lymph node. (D) Total numbers of CD19+ B cells (CD19+/CD45+), (E) 
CD3+ T cells, (F) CD4+ T cells (CD4+/CD45+CD3+), and (G) CD8+ T cells (CD8+/CD45+CD3+) per lymph node. (H) Eosinophils 
(CD11b+, Siglec F+ and SS-HHi/CD45+), (I) neutrophils (CD11b+, Ly6G+/CD45+ Siglec F+ and SS-HHi), (J) monocytes 
(CD11b+, Ly6C+/CD45+ Siglec F+ SS-HHi and Ly6G+), (K) CD11bLow macrophages (CD11bLow, F4/80+/CD45+ Siglec F+ SS-HHi 
Ly6G+ and Ly6C+) and (L) CD11bHi macrophages (CD11bHi, F4/80+/CD45+ Siglec F+ SS-HHi Ly6G+ and Ly6C+), indicated as 
the total number per lymph node. (C-L) The genotype of each mouse is shown below the chart (WT = wild-type, FSN = 
Ttc7fsn/fsn). Bars indicate pooled data with average mean ±SD (n = 7 –10 mice).  
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3.3. Unaffected thymic structure 
Thymi of Ttc7fsn/fsn > WT chimera mice were equal in size and had a normal architecture 
with clearly marked cortical and medullary regions as in control chimeras (Figures 25A, 
25B). Therefore, we did not further investigate this organ.   
 
 
Figure 25. Normal thymic cortical and medullar architecture. (A) Representative photos of thymi from WT > WT and 
Ttc7fsn/fsn > WT chimera mice. (B) Hematoxylin-eosin staining of thymus sections from WT > WT and Ttc7fsn/fsn > WT 
chimera mice. (Magnification: x5). White and black scale bars correspond to 100μm; “M” = Medulla; “C” = Cortex. 
 
This observation suggests that the pre-mature thymic atrophy observed in Ttc7fsn/fsn mice 
is not caused by hematopoietic-derived cells  
 
3.4. Normal forestomach epithelium 
The formation of the forestomach epithelium was not disturbed in Ttc7fsn/fsn > WT chimeras 
(Figures 26A, 26B). This indicates that forestomach papillomas in the Ttc7fsn/fsn mouse 
occur without the influence of the hematopoietic system.  This points towards an intrinsic 
defect in the epithelial cells of Ttc7fsn/fsn mouse.  
 
 
Figure 26. Forestmach papillomas do not develop after bone marrow transfer. (A) Representative photos of 
stomach from WT > WT and Ttc7fsn/fsn > WT chimera mice. (B) Hematoxylin-eosin staining of forestomach sections from 
WT > WT and Ttc7fsn/fsn > WT chimera mice. (Magnification: x10). White and black scale bars correspond to 100μm. 
 
3.5. Healthy skin and normal serum cytokine profiles 
To determine the influence of hematopoietic cells on the skin of bone marrow chimeras 
we analyzed the skin of Ttc7fsn/fsn > WT chimeras. No macro- or microscopic lesions could 
be found in the skin of these mice (Figure 27A). Acanthotic or hyperkeratotic signs were 
 RESULTS 
! 70 
absent, although the mean chimerism level was 67.5% at day 84 after bone marrow 
transfer (Figures 27B, 27C). Similarly, dermal inflammation was not present in bone 
marrow chimeras (Figures 27D, 27E).  
 
 
Figure 27. Hematopoietic-derived cells do not induce flaky skin. (A) Back skin sections of WT > WT and Ttc7fsn/fsn 
chimera mice stained with hematoxylin-eosin reagent and anti-IL22 antibodies (Magnification: x10). Black scale bars 
represent 50μm. (B) Quantification of acanthosis, (C) hyperkeratosis, (D) inflammation of the dermis by total number of 
infiltrates and (E) the number of mast cells in the dermis; (Strategy is described under Figures 17B-E). (F) Serum cytokine 
levels of IL-4, IL-5 and IL-10. (G) Serum cytokine levels of IL-17 and IL-22. (B-E) The genotype is indicated below the 
chart (WT = wild-type, FSN = Ttc7fsn/fsn). Each symbol in the scatter plots corresponds to an individual mouse (n = 5) and 
expresses the mean ±SD values. Bars indicate pooled data from >3 independent experiments as the mean +SD (n = 8 
mice). 
 
Finally, the serum cytokine profiles of IL-4, IL-5, IL-10, IL-17, and IL-22 were measured and 
did not reveal any significant differences between Ttc7fsn/fsn > WT and control bone 
marrow chimeras.  
 
Overall, this data indicates that the hematopoietic system does not transfer the flaky skin 
mutant phenotype. Accordingly, lymphoid cells do not play a central role in inducing the 
flaky skin disease, although they can aggravate the severity.  
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4. Xenograft Model – Dermal-Epidermal Skin Substitutes 
(DESSs) 
After assessing the development of the flaky skin disorder in the presence (bone marrow 
chimera) or absence of Ttc7fsn/fsn lymphocytes (double and triple mutant mice), we set up 
an in vitro co-culture system of stromal and epithelial skin cells across different species. 
This allowed us to specifically study and interrogate the relationship between non-
hematopoietic cell types in the flaky skin phenotype. 
Here, tissue-engineered dermo-epidermal skin substitutes (DESSs, based on collagen 
type I hydrogels) were populated with either WT or Ttc7fsn/fsn fibroblasts and seeded with 
human keratinocytes (Figure 28). The DESSs were then transplanted onto full-thickness 
skin wounds of immunocompromised nude (athymic) rats. Three weeks after 
transplantation, the DESSs were analyzed. 
  
 
 
4.1. Ttc7fsn/fsn fibroblasts drive keratinocyte hyperproliferation 
The analysis of the skin architecture on the DESSs revealed a markedly thicker epidermis 
produced by Ttc7fsn/fsn fibroblasts than by WT fibroblasts (Figure 29B). We used 
immunofluorescence staining to detect loricrin (a major component of the cornified cell 
envelope) and E-cadherin (a transmembrane protein with important functions in 
morphogenesis, the separation of different tissue layers, and cell migration) in 
combination with DAPI. Cell layers co-expressing loricrin and E-cadherin were thicker, 
and the number of cell layers was higher in Ttc7fsn/fsn DESSs than in WT DESSs.  
 
Figure 28. Xenograft Model. 
Schematic structure of the in vitro 
culture system of dermo-epidermal 
skin substitutes (DESSs). 
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Figure 29. In vitro, Ttc7fsn/fsn fibroblasts induce hyperkeratosis in tissue-engineered skin with human 
keratinocytes and athymic rat dermis. (B) Immunochemical staining of loricrin (red) and E-cadherin (green) in 
Ttc7fsn/fsn and WT DESSs on day 21 after transplantation onto athymic nude rats (white arrows indicate the epidermis). 
(C) Immunofluorescence staining of Ki-67 (green) in Ttc7fsn/fsn and control DESSs on day 21 after transplantation onto 
athymic nude rats (white dotted lines indicate the dermo-epidermal junction). (D) Quantification of Ki-67-positive cells 
in the basal cell layer of Ttc7fsn/fsn and control DESSs. The white scale bar corresponds to 100μm. 
 
Despite this difference, the distribution of loricrin and E-cadherin was similar in Ttc7fsn/fsn 
and WT DESSs. In both cases, loricrin was most prominently expressed in the granular 
layer of the epidermis in terminally differentiated keratinocytes. E-cadherin was most 
prominently expressed in the viable epidermis (as is observed in healthy skin in vivo). 
 
Remarkably, in contrast to its restricted expression in the basal layers of WT DESSs, the 
proliferation marker Ki-67 was expressed in both dermal and epidermal layers in Ttc7fsn/fsn 
DESSs (Figure 29C). Moreover, human Ki-67 epidermal cells in the basal layer of Ttc7fsn/fsn 
DESSs were more numerous than the equivalent cells in WT DESSs (Figure 29D). Thus, 
Ttc7fsn/fsn fibroblasts were identified as key players in hyperproliferation of normal 
keratinocytes, even across species borders. 
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5. Next Generation Sequencing of RNA Fibroblast 
 
To gain further insights into Ttc7fsn/fsn fibroblasts, we isolated RNA from primary WT and 
Ttc7fsn/fsn fibroblast cultures and performed next generation sequencing (NGS) analyses.  
 
5.1. Transcriptomic pattern of Ttc7fsn/fsn fibroblasts shows an 
inflammatory pattern, cytoskeleton modeling, and plasma 
membrane pathways and processes 
 
The fact that Ttc7fsn/fsn fibroblasts were able to induce keratinocyte hyperproliferation 
suggests that mutations in Ttc7 alter the expression of regulatory molecules in 
fibroblasts. We therefore used NGS to analyze and compare the transcriptomes in 
Ttc7fsn/fsn and WT fibroblasts. This method revealed that the expression of more than 1,000 
genes was significantly altered in Ttc7fsn/fsn fibroblasts. In the latter, there were more 
upregulated genes than downregulated genes (false discovery rate (FDR) = 0.5, log fold 
change (FC) > 1; Figure 30A). Cluster and MetaCoreTM analyses of the top 10% of genes 
revealed a high degree of variance between Ttc7fsn/fsn and WT fibroblasts. Thus, the genes 
with significantly altered expression could be clustered and associated to key molecular 
pathways (Figures 30B-E; Supplemental Figures 1–4). When comparing Ttc7fsn/fsn 
fibroblasts with WT fibroblasts, six distinct clusters were identified. Upregulated 
transcripts were present in clusters 1, 2, 3, and 5; downregulated transcripts were present 
in cluster 6, and differentially regulated transcripts were present in cluster 4. Genes 
related to cell adhesion, the cytoskeleton, and ECM interactions were significantly 
affected, and they were present in all six clusters (Supplemental Figures 1-5). 
Significantly altered expressions of genes involved in processes related to angiogenesis, 
vasoconstriction, signal transduction, inflammation and immune responses were 
additionally present in all six clusters (Supplemental Figures 1–4). Transcripts related to 
development and multicellular organisms were mainly upregulated (i.e., in clusters 1, 2, 
and 3). Cluster 5 (upregulated genes) generally contained transcripts involved in immune 
cell activation (Supplemental Figures 1–4). Also, cluster 6 grouped pathways and 
processes related to immune responses and inflammation (downregulated transcripts, 
Supplemental Figures 1 and 3).  
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Figure 30A-B. The NGS of fibroblast RNA extracted from WT and Ttc7fsn/fsn mice. 
(A) A scatterplot showing differentially expressed genes in Ttc7fsn/fsn fibroblasts vs. WT fibroblasts on an exponential 
scale. More than 1,000 genes were significantly differentially expressed (p≤0.01). (B) A heat map showing the 
expression patterns for the 2,500 top-ranked genes in six different clusters. Log2-transformed signals are shown 
according to the scale bar (color key). Each column represents an experimental sample, and each row represents a 
gene. Red corresponds to high expression, while blue corresponds to low expression. 
 
When comparing Ttc7fsn/fsn fibroblasts with WT fibroblasts, the overexpression of genes 
involved in cell adhesion, G-protein-coupled-receptor activity and the plasma membrane 
were also revealed by a detailed cluster analysis (Figure 30C, Supplemental Figures 1–
5). 
By performing a gene ontology functional enrichment for endogenous metabolic 
networks and then a MetaCoreTM analysis, we found that the phosphatidylinositol-4,5-
disphosphate (PI(4,5)P2) pathway was the most significantly upregulated pathway in 
Ttc7fsn/fsn fibroblasts when compared with WT fibroblasts (Figure 30D). Together with the 
phosphatidylinositol-3,4,5-triphosphate (PI(3,4,5)P3) pathway at position 10, these two 
metabolic pathways play crucial roles in cytoskeletal regulation and signal transduction. 
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Figure 30C-E. Defined cluster 1-6 and MetaCoreTM analysis of transcriptomic data. (C) The enriched gene ontology 
(GO) categories of clusters 1-6 combining upregulated gene candidates, presented on a p-value (-log10) scale. BP: 
biological process (red); MF: molecular function (blue); CC: cellular component (green). (D) A table showing GO 
enrichment for metabolic network processes of upregulated genes, followed by a MetaCoreTM analysis (endogenous, p 
< 0.05). The top 10 metabolic pathways are listed. (E) Upregulated genes in the phosphatidylinositol-4,5-biphosphate 
pathway, as determined in the MetaCoreTM analyses depicted in (D). 
 
MetaCoreTM pathway analyses of all six clusters simultaneously revealed a set of key 
signaling pathways. These include cytoskeletal remodeling pathways as well as signaling 
pathways related to immune responses and stimulation (Table A). 
When screening for factors that might drive fibroblast and keratinocyte proliferation, we 
observed significantly enhanced expression (p=0.0109, Figure 30F) of insulin-like growth 
factor 1 (IGF-1, cluster 2, and Supplemental Figure 1); IGF-1 is known to induce 
keratinocyte proliferation. The expression of other growth factors, including fibroblast 
growth factors 3, 7, and 10, epidermal growth factors, and others were downregulated 
(data not shown). 
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Table A. The NGS of mouse fibroblasts from WT and Ttc7fsn/fsn. Enriched pathway maps for differentially expressed 
and upregulated genes of all six clusters. The first 20 results out of 50 are listed with the number of counted positive 
hits (count) and their p-values. 
 
Furthermore, all clusters displayed significantly enhanced expression of genes related to 
ECM remodeling. The ECM is involved in most basic cell behaviors, such as cell 
proliferation, adhesion, migration, differentiation, and death [156]. We identified 
alterations in ECM components, such as collagen types III, V, and VI, fibronectin, elastin, 
laminin, and others (Supplemental Figure 6).  
 
 
Figure 30F. (F) Position of upregulated IGF-1 (black arrow) in the scatter dot plot with corresponding p-values (p = 
0.0109) on a log2 scale. 
 
 
 
 
 
Pathway Maps 
pathway term count p-value 
Immune response IL-6 signaling pathway via JAK/STAT 42/72 2.012e-13 
Transcription Epigenetic regulation of gene expression 35/57 2.562e-12 
Development, Insulin, IGF-1 and TNF-alpha in brown adipocyte 
differentiation 33/52 2.888e-12 
Apoptosis and survival FAS signaling cascades 29/44 1.530e-11 
Cytoskeleton remodeling, TGF, WNT and cytoskeletal remodeling 52/111 2.917e-11 
Signal transduction mTORC1 downstream signaling 35/61 3.975e-11 
Immune response IL-3 signaling via ERK and PI3K 48/102 1.382e-10 
Transcription Sirtuin6 regulation and function 35/64 2.469e-10 
Signal transduction of mTORC2 downstream signaling 36/68 4.624e-10 
Immune response IFN-alpha/beta signaling via MAPKs 39/77 4.918e-10 
Development, cytokine-mediated regulation of megakaryopoiesis 32/57 5.909e-10 
Apoptosis and survival, Caspase activity 23/34 9.259e-10 
Transcription, p53 signaling pathway 25/39 9.586e-10 
Cytoskeleton remodeling 45/102 6.703e-9 
Apoptosis and survival NGF/TrkA PI3K-mediated signaling 37/77 8.794e-9 
Immune response IL-6 signaling pathway via MEK/ERK and PI3K/AKT 
cascade 36/74 9.210e-9 
Putative pathway for stimulation of fat cell differentiation by Bisphenol A 21/32 1.164e-8 
Immune response, IL-4 signaling pathway 42/94 1.349e-8 
Aopoptosis and survival, Granzyme B signaling 21/33 2.621e-8 
Development FLT3 signaling 25/44 3.282e-8 
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Altogether, this data shows that the Ttc7 mutation in fibroblasts is associated with 
alterations in the expression of many genes. The fibroblasts play a critical role in 
regulating epithelial proliferation and might also influence surrounding cells in the 
dermis. An array of processes at the plasma membrane appears to be particularly 
affected. This includes the PI(4,5)P2 pathway and important components of cell adhesion 
and receptor signaling processes. These changes might influence cell–cell interaction, cell 
development, cell differentiation, and inflammation. The disturbance of processes in the 
plasma membrane might explain why a Ttc7 mutation with minor cell-intrinsic 
consequences has effects on neighboring cells — even when the latter express WT Ttc7. 
Taken as a whole, this is line with a hyper-responsiveness of stromal cells, which has been 
observed in isolated Ttc7fsn/fsn lymphocytes in previous publications [121, 128, 150]. 
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5.1.1. Supplemental Figures 1 — 6 
 
Supplemental Figure 1. Next generation sequencing of mouse fibroblasts from WT and Ttc7fsn/fsn mice. The 
enriched pathway maps for differentially expressed genes for clusters 1 to 6. The first 10 results of each cluster are 
listed.  
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Supplemental Figure 2. Next generation sequencing of mouse fibroblasts from WT and Ttc7fsn/fsn mice. The 
enriched GO processes for differentially expressed genes for clusters 1 to 6. The first 10 results of each cluster are listed. 
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Supplemental Figure 3. Next generation sequencing of mouse fibroblasts from WT and Ttc7fsn/fsn mice. The 
enriched process networks for differentially expressed genes for clusters 1 to 6. The first 10 results of each cluster are 
listed. 
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Supplemental Figure 4. Next generation sequencing of mouse fibroblasts from WT and Ttc7fsn/fsn mice. The 
enriched GO of molecular function for differentially expressed genes for clusters 1 to 6. The first 10 results of each 
cluster are listed. 
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Supplemental Figure 5. Next generation sequencing of mouse fibroblasts from WT and Ttc7fsn/fsn mice. The 
enriched GO of cellular localization for differentially expressed genes for clusters 1 to 6. The first 10 results of each 
cluster are listed. 
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Supplemental Figure 6. Next generation sequencing of mouse fibroblasts from WT and Ttc7fsn/fsn mice. Lists of 
statistically significant up- and down-regulated genes of the extracellular matrix and list of up-regulated integrins in 
cell adhesion, cell-matrix interaction processes.  
 
 
 DISCUSSION 
! 86 
VI. DISCUSSION 
In the case of TTC7A deficiency, there is an ongoing debate about whether TTC7A 
mutations dysregulate epithelial cell functions alone or in combination with T cells’ 
intrinsic functions. In the flaky skin mutant mouse (Ttc7fsn/fsn), a murine model of TTC7A 
deficiency, we analyzed whether the epithelial phenotype is influenced by other cell 
types. We found that the hyperproliferative skin disease developed in the absence of 
lymphocytes. We furthermore observed that Ttc7fsn/fsn hematopoietic cells do not per se 
induce pathological changes when transferred to wild-type (WT) animals. Remarkably, 
Ttc7fsn/fsn fibroblasts disordered the proliferation of normal human epithelial cells in 
dermo–epidermal skin cultures and displayed an array of transcriptomic alterations in 
molecular networks required for cell–cell interactions. Our results show that defective 
Ttc7 in the flaky skin mutant mouse model is associated with fibroblast-driven 
keratinocyte hyperproliferation and lymphocyte-propagated skin inflammation in the 
presence of the proliferation-inducing factors IL-22 and IGF-1. Thus, our results indicate 
that Ttc7 plays a critical role in the crosstalk between cells from different tissues. 
 
It is worthwhile to mention that other researchers have also encountered the 
involvement of fibroblasts in keratinocyte hyperproliferation. In co-cultures with dermal 
fibroblasts from psoriatic patients, keratinocytes from healthy donors showed 
hyperproliferation on in vitro skin equivalents [157]. This observation points toward a 
diffusible factor from fibroblasts which may also be involved in our system, irrespective 
of the question whether the flaky skin mouse should be regarded as a model for 
psoriasiform dermatitis or a disease in the group of syndromic ichthyosis, as proposed 
by some researchers [125, 126, 130]. The importance of growth-factor mediated cross-
talk between keratinocytes and fibroblasts also becomes evident during cutaneous 
tissue repair aiming to restore and maintain the barrier function of the skin [79]. With a 
view to identifying such factors in Ttc7fsn/fsn fibroblasts, we compared the latter’s 
transcriptome with the one of their WT counterparts. Overall, our transcriptomic 
analyses revealed that various endogenous cellular functions in the fibroblasts were 
altered. With regard to factors that might influence the growth of keratinocytes, we 
found that transcription of the IGF1 gene was markedly upregulated in Ttc7fsn/fsn 
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fibroblasts, but this was not the case for other growth factors such as FGF3, FGF7, 
FGF10, or EGF.  
 
We observed elevated serum levels of IL-22 in all mouse strains with Ttc7fsn/fsn germline 
mutation. IL-22 is mainly produced by different leukocyte subtypes but can also be 
produced by stromal cells under harmful condition [158, 159]. Therefore, IL-22 is 
another candidate that could play an important role in the pathogenesis of the 
hyperproliferative skin disease. We observed elevated serum levels of IL-22 even in 
Ttc7fsn/fsn mice crossed with Rag2-/- and Rag2-/-IL2rg-/- mice. Remarkably, IL-22 serum levels 
were particularly elevated in the mice lacking all lymphoid cells. Using anti-IL-22 
antibodies in immunohistochemical staining, we identified mast cells as being strongly 
positive. In contrast, based on transcriptome data and immunohistochemistry, 
fibroblasts did not seem to be a major source for IL-22 in Ttc7fsn/fsn mice. Thus, our data 
suggest that mast cells were the predominant non-lymphoid source for IL-22 in the 
Ttc7fsn/fsn strains [160-163]. Mast cells and Neutrophils are known to play a prominent role 
in different skin diseases [164, 165]. In the Ttc7fsn/fsn mouse, the phenotype could not be 
transferred by hematopoietic stem cell transplants. We therefore think that, if IL-22 is 
predominately produced by mast cells, it is not needed to trigger the skin disease. 
Lastly, serum levels of IL-17 were only elevated in Ttc7fsn/fsn mice and were not increased 
or null in Ttc7fsn/fsn mice crossed with Rag2-/- or Rag2-/-IL2rg-/- mice, reflecting a lymphoid-
restricted source of IL-17. Hence, IL-22 and IL-17 are both probably not the key factor in 
inducing hyperproliferative skin disease in the flaky skin model. Nevertheless, both 
cytokines may exacerbate the phenotype. 
 
It is noteworthy that within the heterodimeric IL-22 receptor, specifically IL-22R1 has a 
tightly regulated expression and is predominantly found on cells of epithelial origin, 
including intestinal and lung epithelial cells and keratinocytes [71]. Based on the known 
function of IL-22 in upregulating anti-bacterial peptides such as defensins and lipocalin 
[166, 167], skin inflammation in Ttc7fsn/fsn mice might be a consequence of abnormal 
epidermal barrier dysfunction due to hyperproliferation and subsequent IL-22-
mediated inflammation perpetuating keratinocyte proliferation.  
A previous study using immunofluorescence analysis showed elevated numbers of 
Langerhans cells and Thy-1+ dendritic epidermal cells in skin sections of Ttc7fsn/fsn mice, 
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suggesting an immune-system-related abnormality [168]. We cannot rule out an effect 
of Langerhans cells on the skin phenotype in our mouse models. However, the results of 
our Rag2-/- crossing experiment confirmed that γδTCR-expressing Thy-1+ dendritic 
epithelial cells (DETCs) are not the main elicitors of the skin disease. 
 
As exemplified by our findings in the flaky skin mutant mouse, the pathogenesis 
underlying an immunodeficiency disease can also originate from major defects in non-
hematopoietic-derived cells. Our work thus calls the prevailing therapeutic strategy of 
hematopoietic stem cell transplantation for TTC7A deficiency into question. Systemic 
therapeutic agents therefore represent promising tools directed at the specific disease-
causing abnormality. The target of such therapeutic agents has to be able to regulate 
cellular functions that are activated or suppressed to compensate for altered 
functionality of the affected gene. The analyses of transcriptomic data from Ttc7-
mutated fibroblasts displayed an mRNA expression pattern that suggested alterations 
in phosphoinositide-dependent key signaling pathways. The list of these key-signaling 
pathways indicates the ERK and PI3K pathways to be important players in cellular 
functions. The extracellular signal-regulated kinase (ERK) and phosphatidylinositol 3-
kinase (PI3K) pathway are evolutionarily conserved and present in various cells. Both 
pathways are involved in controlling many fundamental cellular processes that include 
cell proliferation, survival, differentiation, apoptosis, motility, and metabolism, and they 
may have a cross-regulating function [169, 170]. It has been noted that the 
phosphorylation of ERK is elevated in transitional B cells in the Ttc7fsn/fsn mouse [171].  
 
Our effort at finding a potential target has led us to the observation that Ttc7fsn/fsn 
fibroblasts synthetize increased RNA expression of IGF-1. This is in accordance with 
previous publications, showing that the major sources of IGF-1 in the skin are dermal 
fibroblasts [172]. The insulin-like growth factor 1 receptor (IGF-1R) is expressed by 
epithelial and immune cell [173-175]. Activated IGF-1R triggers several signaling 
cascades, including PI3K and MAPK pathways [176]. Early in vivo studies have 
demonstrated that the Igf-1 receptor on the cell surface of keratinocytes is confined to 
the basal layer of the epidermis [177]. In the skin, the IGF-1 system is used by 
keratinocytes for epidermal development and maintenance [178, 179]. Keratinocyte 
proliferation is restricted to the basal layer. Upon division, keratinocytes do either 
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replace progenitor cells or undergo terminal differentiation to become fully mature 
corneocytes at the outer surface of the epidermis [180]. Overexpression of IGF-1 in the 
skin results in epidermal “hyperthickening” and spontaneous tumor formation, whereas 
IGF-1R-deficient mice present an underdeveloped epidermis [181]. Nevertheless, several 
endogenous substances regulate proliferation and growth of keratinocytes. Our study 
of the cytokine signatures between different mouse strains has also highlighted that IL-
4, IL-17, and IL-22 are main factors characterizing the hyper-proliferative immune 
response in Ttc7fsn/fsn mice. This raises the question as to whether targeting these 
cytokines individually, simultaneously or together with IGF-1 or targets in the ERK/PI3K 
pathway could reverse the phenotype.  
 
We do report a multiple-organ defect in Ttc7fsn/fsn mice but with different organs being 
affected to varying degrees. There might be the possibility of yet unknown 
compensatory mechanisms that could be more active in some cell types than others. In 
humans, TTC7A defects show developmental disorders in form of atresia, whereas in the 
Ttc7fsn/fsn mouse model, the onset of the skin defect develops later supporting the 
possibility of species-specific difference in the function of TTC7A, respectively Ttc7. This 
also strengthens the possibility of compensatory mechanisms that could be more active 
during developmental stages in mice [182]. It is also important to note that there might 
be differences in the reaction of soluble factors such as IL-22 dependent on the organ-
specific environment. For instance, the intestinal epithelium comprises several intestinal 
epithelial cell (IEL) lineages with distinct functions [183]. The IL-22 receptor is expressed 
on IECs [184], and IL-22 plays an important role in the maintenance of intestinal 
epithelial polarity when gut tissue is damaged by various disorders, such as IBD and 
GvHD [185, 186]. This protective function of IL-22 in IBD could further explain why the 
Ttc7fsn/fsn mouse does not present with intestinal symptoms, in contrast to humans. 
However, in humans, inverted apicobasal polarity of patients’ enterocytes has been 
shown in pathological assessments of gut biopsies and was recapitulated in patient-
derived organoid cultures [107, 108]. In the presence of RhoA kinase inhibitors, the 
abnormal polarity of epithelial cells was reversed. RhoA kinase might therefore be 
another interesting therapeutic target also in mice.  
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It has been suggested, that Ttc7 controls the spatial synthesis of phosphatidylinositol 4-
phosphates at the plasma membrane (PI4P), the metabolic precursor of PI(4,5)P2. 
PI(4,5)P2 is important for cell regulation and membrane dynamics, including 
endocytosis, cell motility, cell adhesion, or signaling transduction. All these cellular 
processes could be affected by mutated Ttc7. Our transcriptomic analysis revealed that 
several cellular functions in the Ttc7-mutated fibroblasts themselves are disrupted. 
Bearing in mind that Ttc7 is a ubiquitously expressed protein, all cell–cell interactions 
could therefore induce an aberrant cellular behavior.  
 
In conclusion, our data opt for a multi-facetted interaction network consisting of 
fibroblasts, epithelial cells, and hematopoietic cells as driving force in the 
pathomechanism leading to the flaky skin phenotype. Our findings highlight a function 
of fibroblasts in controlling cellular behavior and epithelial cell proliferation, while the 
soluble factors (i) IGF-1 and (ii) IL-22 play a role together with lymphocytes in 
aggravating skin inflammation in the Ttc7fsn/fsn mouse model.  
Indeed, Ttc7 appears to play a central role in different cellular dynamics and behaviors. 
The dysfunctional crosstalk between stromal cells adds an unsuspected new dimension 
to the pathogenesis of the multisystemic disease associated with TTC7A-deficiency. This 
suggested mechanism reveals why previous HSCT treatments together with intestinal 
surgery may only partially relieve the multisystemic disease seen in patients with TTC7A 
deficiency, and also provides potential new molecular targets for achieving systemic 
therapeutic effects that intervene in the disturbed interaction between stromal cells. 
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